FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Volker Diehl

Research Profile

Disorders

Hodgkin's Disease

Procedures

Chemicals & Drugs

Concepts & Ideas

Anatomy

Living Beings

Mouse

Co-author Network

Publications

TOP 3
Boris Böll; Mario J Bargetzi; Volker Diehl; Hans Theodor Eich; Dennis A Eichenauer; Andreas Engert; Michael Fuchs; Helen Görgen; Richard Greil; Christian Junghanß; Annette Pluetschow; Achim Rothe; Alexander Scherpe; Oliver Schmalz; Bastian Von Tresckow; Eckhart Weidmann; Peter Borchmann
ABVD in Older Patients With Early-Stage Hodgkin Lymphoma Treated Within the German Hodgkin Study Group HD10 and HD11 Trials.
Karolin Behringer; Volker Diehl; Angelika Diana Eibl; Andreas Engert; Michael Fuchs; Helen Goergen; Teresa Halbsguth; Marietta Kuehr; Horst Mueller; Katrin S Reiners; Jorg H Renno; Johannes Rosenbrock; Thomas Schober; Volker Stumpf; Indra Thielen; Katrin van der Ven; Michael von Wolff; Carsten Wessels; Martin Wiehlpütz; Peter Borchmann
Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials.
S Sasse; G Trenn; M Wilhelm; Peter Borchmann; Volker Diehl; Hans Theodor Eich; Andreas Engert; J Finke; M Fuchs; H Görgen; A Heyden-Honerkamp; Beate Klimm; O Koch; Andreas Lohri; Rolf-Peter Müller
Comparing long-term toxicity and efficacy of combined modality treatment including extended- or involved-field radiotherapy in early-stage Hodgkin's lymphoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Volker Diehl (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Boris Böll; Mario J Bargetzi; Volker Diehl; Hans Theodor Eich; Dennis A Eichenauer; Andreas Engert; Michael Fuchs; Helen Görgen; Richard Greil; Christian Junghanß; Annette Pluetschow; Achim Rothe; Alexander Scherpe; Oliver Schmalz; Bastian Von Tresckow; Eckhart Weidmann; Peter Borchmann
ABVD in Older Patients With Early-Stage Hodgkin Lymphoma Treated Within the German Hodgkin Study Group HD10 and HD11 Trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(12):1522-9.
2013: Karolin Behringer; Volker Diehl; Angelika Diana Eibl; Andreas Engert; Michael Fuchs; Helen Goergen; Teresa Halbsguth; Marietta Kuehr; Horst Mueller; Katrin S Reiners; Jorg H Renno; Johannes Rosenbrock; Thomas Schober; Volker Stumpf; Indra Thielen; Katrin van der Ven; Michael von Wolff; Carsten Wessels; Martin Wiehlpütz; Peter Borchmann
Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(2):231-9.
2012: S Sasse; G Trenn; M Wilhelm; Peter Borchmann; Volker Diehl; Hans Theodor Eich; Andreas Engert; J Finke; M Fuchs; H Görgen; A Heyden-Honerkamp; Beate Klimm; O Koch; Andreas Lohri; Rolf-Peter Müller
Comparing long-term toxicity and efficacy of combined modality treatment including extended- or involved-field radiotherapy in early-stage Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(11):2953-9.
2012: Karolin Behringer; Volker Diehl; A D Eibl; D A Eichenauer; Andreas Engert; M Fuchs; H Goergen; T Halbsguth; M Kuehr; H Mueller; K S Reiners; J H Renno; J Rosenbrock; I Thielen; K van der Ven; M von Wolff; Peter Borchmann
Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(7):1818-25.
2012: Bastian Von Tresckow; Josée M Zijlstra; Peter Borchmann; Volker Diehl; Hans Theodor Eich; Michael Fuchs; richard greil; Beate Klimm; Zdenek Kral; Andreas Lohri; Jana Markova; Julia Meissner; Rolf-Peter Mueller; Annette Plütschow; Martin Soekler; Harald Stein; Max S Topp; Andreas Engert
Dose-intensification in early unfavorable Hodgkin's lymphoma: final analysis of the German hodgkin study group HD14 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(9):907-13.
2011: Peter Borchmann; Thomas Cerny; Volker Diehl; Bernd Dörken; Hans Theodor Eich; Michael Fuchs; richard greil; Heinz Haverkamp; Anthony D Ho; Christoph Huber; Lothar Kanz; Stefan W Krause; Jana Markova; Rolf-Peter Mueller; Hans-Konrad Mueller-Hermelink; Christoph Nerl; Ursula Paulus; Andreas Rank; Lenka Smardova; Andreas Engert
Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(32):4234-42.
2011: Peter Borchmann; Andreas Engert; Volker Diehl
Chemotherapy: Hodgkin lymphoma--absence of evidence not evidence of absence!
Nature reviews. Clinical oncology 2011;8(11):636-7.
2011: Beate Klimm; Harald Stein; Jeremy Franklin; Michael Fuchs; Heinz Haverkamp; Peter Borchmann; Volker Diehl; Dennis A Eichenauer; Andreas Engert
Lymphocyte-depleted classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin study group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(29):3914-20.
2011: M Scholz; A Engert; J Franklin; A Josting; Volker Diehl; Dirk Hasenclever; Markus Loeffler
Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(3):681-8.
2010: Andreas Josting; Horst Müller; Peter Borchmann; Joke W Baars; B Metzner; Hartmut Döhner; Igor Aurer; Lenka Smardova; Thomas Fischer; Dietger Niederwieser; Kerstin Schäfer-Eckart; Norbert Schmitz; Anna Sureda; Jan-Peter Glossmann; Volker Diehl; Daphne DeJong; Martin-Leo Hansmann; John Raemaekers; Andreas Engert
Dose intensity of chemotherapy in patients with relapsed Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(34):5074-80.
2010: Boris Böll; Peter Borchmann; Volker Diehl
Emerging drugs for Hodgkin's lymphoma.
Expert opinion on emerging drugs 2010;15(4):585-95.
2010: Karolin Behringer; Ludwig Wildt; H Mueller; V Mattle; P Ganitis; B van den Hoonaard; H W Ott; S Hofer; A Pluetschow; Volker Diehl; Andreas Engert; Peter Borchmann
No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(10):2052-60.
2010: Teresa V Halbsguth; Lucia Nogová; Horst Mueller; Michal Sieniawski; Dennis A Eichenauer; Thomas Schober; Hiltrud Nisters-Backes; Peter Borchmann; Volker Diehl; Andreas Engert; Andreas Josting
Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG).
Blood 2010;116(12):2026-32.
2010: Hans Theodor Eich; Volker Diehl; Helen Görgen; Thomas Pabst; Jana Markova; Jürgen Debus; Anthony Ho; Bernd Dörken; Andreas Rank; Anca-Ligia Grosu; Thomas Wiegel; Johann Hinrich Karstens; richard greil; Normann Willich; Heinz Schmidberger; Hartmut Döhner; Peter Borchmann; Hans Konrad Müller-Hermelink; Rolf-Peter Müller; Andreas Engert
Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(27):4199-206.
2010: Volker Diehl
Hematology. Are macrophages the bad guys in Hodgkin lymphoma?
Nature reviews. Clinical oncology 2010;7(6):301-2.
2010: Andreas Engert; Andreas Josting; Heinz Haverkamp; Matthias Villalobos; Andreas Lohri; Martin Sökler; Josée Zijlstra; Isrid Sturm; Max S Topp; Andreas Rank; Thorsten Zenz; Martin Vogelhuber; Lucia Nogova; Peter Borchmann; Michael Fuchs; Hans-Henning Flechtner; Volker Diehl
Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(13):2239-45.
2009: Dennis A Eichenauer; Henning Bredenfeld; Heinz Haverkamp; Horst Müller; Jeremy Franklin; Michael Fuchs; Peter Borchmann; Hans Konrad Müller-Hermelink; Hans Theodor Eich; Rolf-Peter Müller; Volker Diehl; Andreas Engert
Hodgkin's lymphoma in adolescents treated with adult protocols: a report from the German Hodgkin study group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(36):6079-85.
2009: Andreas Engert; Volker Diehl; Jeremy Franklin; Andreas Lohri; Bernd Dörken; Wolf-Dieter Ludwig; Peter Koch; Mathias Hänel; Michael Pfreundschuh; Martin Wilhelm; Lorenz Trümper; Walter-Erich Aulitzky; Martin Bentz; Mathias Rummel; Orhan Sezer; Hans Konrad Müller-Hermelink; Dirk Hasenclever; Markus Loeffler
Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(27):4548-54.
2009: Volker Diehl
The bridge between patient and doctor: the shift from CAM to integrative medicine.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2009;():320-5.
2008: Carsten Kobe; Markus Dietlein; Jeremy Franklin; Jana Markova; Andreas Lohri; Holger Amthauer; Susanne Klutmann; WH Knapp; Josee M Zijlstra; Andreas Bockisch; Matthias Weckesser; Reinhard Lorenz; Mathias Schreckenberger; Roland Bares; Hans Theodor Eich; Rolf-Peter Mueller; Michael Fuchs; Peter Borchmann; Harald Schicha; Volker Diehl; Andreas Engert
Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma.
Blood 2008;112(10):3989-94.
2008: Roger Rautert; Timo Schinköthe; Jeremy Franklin; Martin R Weihrauch; Boris Boll; Elke Pogge; Henning Bredenfeld; Andreas Engert; Volker Diehl; Daniel Re
Elevated pretreatment interleukin-10 serum level is an International Prognostic Score (IPS)-independent risk factor for early treatment failure in advanced stage Hodgkin lymphoma.
Leukemia & lymphoma 2008;49(11):2091-8.
2008: Michal Sieniawski; Thorsten Reineke; Andreas Josting; Lucia Nogova; K Behringer; T Halbsguth; M Fuchs; Volker Diehl; Andreas Engert
Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(10):1795-801.
2008: Michael Fuchs; Dennis A Eichenauer; Lucia Nogová; Volker Diehl; Andreas Engert
Nodular lymphocyte-predominant Hodgkin lymphoma.
Current hematologic malignancy reports 2008;3(3):126-31.
2008: Lucia Nogová; Thorsten Reineke; Corinne Brillant; Michal Sieniawski; Thomas Rüdiger; Andreas Josting; Henning Bredenfeld; Roman Skripnitchenko; Rolf-Peter Müller; Hans Konrad Müller-Hermelink; Volker Diehl; Andreas Engert
Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(3):434-9.
2008: Holger Schulz; Ute Rehwald; Franck Morschhauser; Thomas Elter; Christoph Driessen; Thomas Rüdiger; Peter Borchmann; Roland Schnell; Volker Diehl; Andreas Engert; Marcel Reiser
Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG).
Blood 2008;111(1):109-11.
2008: Michal Sieniawski; Thorsten Reineke; Lucia Nogova; Andreas Josting; Beate Pfistner; Volker Diehl; Andreas Engert
Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG).
Blood 2008;111(1):71-6.
2008: Andrew Macann; Henning Bredenfeld; Rolf-Peter Müller; Volker Diehl; Andreas Engert; Hans Theodor Eich
Radiotherapy does not influence the severe pulmonary toxicity observed with the administration of gemcitabine and bleomycin in patients with advanced-stage Hodgkin's lymphoma treated with the BAGCOPP regimen: a report by the German Hodgkin's Lymphoma Study Group.
International journal of radiation oncology, biology, physics 2008;70(1):161-5.
2007: Hans Theodor Eich; Axel Gossmann; Andreas Engert; Jan Kriz; Henning Bredenfeld; Katja Hansemann; Roman Skripnitchenko; Corinne Brillant; Beate Pfistner; Susanne Staar; Volker Diehl; Rolf-Peter Müller
A Contribution to solve the problem of the need for consolidative radiotherapy after intensive chemotherapy in advanced stages of Hodgkin's lymphoma--analysis of a quality control program initiated by the radiotherapy reference center of the German Hodgkin Study Group (GHSG).
International journal of radiation oncology, biology, physics 2007;69(4):1187-92.
2007: Andreas Engert; Jeremy Franklin; Hans Theodor Eich; Corinne Brillant; Susanne Sehlen; Claudio Cartoni; Richard Herrmann; Michael Pfreundschuh; Markus Sieber; Hans Tesch; Astrid Franke; Peter Koch; Maike de Wit; Ursula Paulus; Dirk Hasenclever; Markus Loeffler; Rolf-Peter Müller; Hans Konrad Müller-Hermelink; Eckhart Dühmke; Volker Diehl
Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(23):3495-502.
2007: Volker Diehl; Michael Fuchs
Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2007;37(1):37-41.
2007: Berthe M P Aleman; Daniel Re; Volker Diehl
The role of radiation therapy in patients with Hodgkin's lymphoma.
Current hematologic malignancy reports 2007;2(3):151-60.
2007: Volker Diehl; M Fuchs
Early, intermediate and advanced Hodgkin's lymphoma: modern treatment strategies.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18 Suppl 9():ix71-9.
2007: Michal Sieniawski; Jeremy Franklin; Lucia Nogova; Jan-Peter Glossmann; Thomas Schober; Hiltrud Nisters-Backes; Volker Diehl; Andreas Josting
Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):2000-5.
2007: Michal Sieniawski; Oliver Staak; Jan-Peter Glossmann; Thorsten Reineke; Helena Scheuss; Volker Diehl; Andreas Engert; Andreas Josting
Rituximab added to an intensified salvage chemotherapy program followed by autologous stem cell transplantation improved the outcome in relapsed and refractory aggressive non-Hodgkin lymphoma.
Annals of hematology 2007;86(2):107-15.
2007: Beate Klimm; Hans Theodor Eich; Heinz Haverkamp; Andreas Lohri; Peter Koch; Friederike Boissevain; G Trenn; P Worst; Eckhart Dühmke; Rolf-Peter Müller; K Müller-Hermelink; Beate Pfistner; Volker Diehl; Andreas Engert
Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(2):357-63.
2007: Stefan Wilde; Alexander Jetter; Stephan Rietbrock; Dirk Kasel; Andreas Engert; Andreas Josting; Beate Klimm; Georg Hempel; Stefanie Reif; Ulrich Jaehde; Ute Merkel; Dagmar Busse; Matthias Schwab; Volker Diehl; Uwe Fuhr
Population pharmacokinetics of the BEACOPP polychemotherapy regimen in Hodgkin's lymphoma and its effect on myelotoxicity.
Clinical pharmacokinetics 2007;46(4):319-33.
2007: Martin Schwonzen; Volker Diehl; Mario Dellanna; Peter Staib
Immunophenotyping of surface antigens in acute myeloid leukemia by flow cytometry after red blood cell lysis.
Leukemia research 2007;31(1):113-6.
2006: Jeremy Franklin; A Pluetschow; M Paus; L Specht; Anna Paola Anselmo; A Aviles; G Biti; T Bogatyreva; G Bonadonna; Corinne Brillant; Elena Cavalieri; Volker Diehl; Houchingue Eghbali; Christophe Fermé; Michel Henry-Amar; R Hoppe; S Howard; R Meyer; D Niedzwiecki; S Pavlovsky; J Radford; John M M Raemaekers; D Ryder; Petra Schiller; S Shakhtarina; P Valagussa; J Wilimas; Joachim Yahalom
Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(12):1749-60.
2006: Volker Diehl; Karolin Behringer
Could BEACOPP be the new standard for the treatment of advanced Hodgkin's lymphoma?
Cancer investigation 2006;24(4):461-5.
2006: Andreas Draube; Karolin Behringer; Volker Diehl
German Hodgkin's Lymphoma Study Group trials: lessons from the past and current strategies.
Clinical lymphoma & myeloma 2006;6(6):458-68.
2006: Andreas Engert; Henning Bredenfeld; Hartmut Döhner; Anthony Ho; Norbert Schmitz; Dietmar Berger; Pamela Bacon; Tomas Skacel; Valerie Easton; Volker Diehl
Pegfilgrastim support for full delivery of BEACOPP-14 chemotherapy for patients with high-risk Hodgkin's lymphoma: results of a phase II study.
Haematologica 2006;91(4):546-9.
2006: Lucia Nogovà; Volker Diehl; Andreas Engert
Nodular lymphocyte-predominant Hodgkin's lymphoma.
Current hematologic malignancy reports 2006;1(1):60-5.
2006: Beate Klimm; Andreas Engert; Volker Diehl
First-line treatment of Hodgkin's lymphoma.
Current hematologic malignancy reports 2006;1(1):51-9.
2006: Peter Borchmann; Karolin Behringer; Andreas Josting; J U Rueffer; Roland Schnell; Volker Diehl; Andreas Engert; Hans Michael Kvasnicka; Hans Michael Kvasnicka
[Secondary malignancies after successful primary treatment of malignant Hodgkin's lymphoma].
Der Pathologe 2006;27(1):47-52.
2005: Susanne Rödel; Andreas Engert; Volker Diehl; Marcel Reiser
Combination chemotherapy with adriamycin, cyclophosphamide, vincristine, methotrexate, etoposide and dexamethasone (ACOMED) followed by involved field radiotherapy induces high remission rates and durable long-term survival in patients with aggressive malignant non-Hodgkin's lymphomas: long-term follow-up of a pilot study.
Leukemia & lymphoma 2005;46(12):1729-34.
2005: Beate Klimm; Roland Schnell; Volker Diehl; Andreas Engert
Current treatment and immunotherapy of Hodgkin's lymphoma.
Haematologica 2005;90(12):1680-92.
2005: JU Rüffer; Veronika Ballova; Jan-Peter Glossmann; Markus Sieber; Jeremy Franklin; Lucia Nogova; Volker Diehl; Andreas Josting
BEACOPP and COPP/ABVD as salvage treatment after primary extended field radiation therapy of early stage Hodgkins disease - results of the German Hodgkin Study Group.
Leukemia & lymphoma 2005;46(11):1561-7.
2005: Beate Klimm; Thorsten Reineke; Heinz Haverkamp; Karolin Behringer; Hans Theodor Eich; Andreas Josting; Beate Pfistner; Volker Diehl; Andreas Engert
Role of hematotoxicity and sex in patients with Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(31):8003-11.
2005: Hans Theodor Eich; Uwe Haverkamp; Andreas Engert; Martin Kocher; Roman Skripnitchenko; Corinne Brillant; Susanne Sehlen; Eckhart Dühmke; Volker Diehl; Rolf-Peter Müller
Biophysical analysis of the acute toxicity of radiotherapy in Hodgkin's lymphoma--a comparison between extended field and involved field radiotherapy based on the data of the German Hodgkin Study Group.
International journal of radiation oncology, biology, physics 2005;63(3):860-5.
2005: Karolin Behringer; Kai Breuer; Thorsten Reineke; Michael May; Lucia Nogova; Beate Klimm; Tatiana Schmitz; Ludwig Wildt; Volker Diehl; Andreas Engert
Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(30):7555-64.
2005: Lucia Nogová; T Reineke; Hans Theodor Eich; Andreas Josting; Hans Konrad Müller-Hermelink; K Wingbermühle; Corinne Brillant; A Gossmann; J Oertel; M V Bollen; Rolf-Peter Müller; Volker Diehl; Andreas Engert
Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(10):1683-7.
2005: Alexander Shimabukuro-Vornhagen; Heinz Haverkamp; Andreas Engert; Leopold Balleisen; Peter Majunke; Günther Heil; Hans Theodor Eich; Harald Stein; Volker Diehl; Andreas Josting
Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5739-45.
2005: Martin R Weihrauch; Sascha Ansén; Elke Jurkiewicz; Caroline Geisen; Zhinan Xia; Karen S Anderson; Edith Gracien; Manuel Schmidt; Burghardt Wittig; Volker Diehl; Juergen Wolf; Heribert Bohlen; Lee M Nadler
Phase I/II combined chemoimmunotherapy with carcinoembryonic antigen-derived HLA-A2-restricted CAP-1 peptide and irinotecan, 5-fluorouracil, and leucovorin in patients with primary metastatic colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(16):5993-6001.
2005: Andreas Engert; Veronika Ballova; Heinz Haverkamp; Beate Pfistner; Andreas Josting; Eckhart Dühmke; Konrad Müller-Hermelink; Volker Diehl
Hodgkin's lymphoma in elderly patients: a comprehensive retrospective analysis from the German Hodgkin's Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):5052-60.
2005: Andreas Josting; Michal Sieniawski; Jan-Peter Glossmann; O Staak; Lucia Nogova; N Peters; MY Mapara; Bernd Dörken; Y Ko; B Metzner; Jens Kisro; Volker Diehl; Andreas Engert
High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(8):1359-65.
2005: Jan-Peter Glossmann; Jan Oliver Staak; Lucia Nogova; Volker Diehl; Christof Scheid; Jens Kisro; Hans-Edgar Reis; Norma Peter; Andreas Engert; Andreas Josting
Autologous tandem transplantation in patients with primary progressive or relapsed/refractory lymphoma.
Annals of hematology 2005;84(8):517-25.
2005: Roland Schnell; Markus Dietlein; Jan Oliver Staak; Peter Borchmann; Klaus Schomaecker; Thomas Fischer; Wolfgang Eschner; Hinrich Hansen; Franck Morschhauser; Harald Schicha; Volker Diehl; Andrew Raubitschek; Andreas Engert
Treatment of refractory Hodgkin's lymphoma patients with an iodine-131-labeled murine anti-CD30 monoclonal antibody.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(21):4669-78.
2005: L Smardova; Andreas Engert; Heinz Haverkamp; Jm Raemakers; Jw Baars; Beate Pfistner; Volker Diehl; Andreas Josting
Successful mobilization of peripheral blood stem cells with the DHAP regimen (dexamethasone, cytarabine, cisplatinum) plus granulocyte colony-stimulating factor in patients with relapsed Hodgkin's disease.
Leukemia & lymphoma 2005;46(7):1017-22.
2005: Beate Klimm; Volker Diehl; Beate Pfistner; Andreas Engert
Current treatment strategies of the German Hodgkin Study Group (GHSG).
European journal of haematology. Supplementum 2005;(66):125-34.
2005: Lucia Nogová; Thorsten Reineke; Andreas Josting; Hans Konrad Müller-Hermelink; Hans Theodor Eich; Karolin Behringer; Rolf-Peter Müller; Volker Diehl; Andreas Engert
Lymphocyte-predominant and classical Hodgkin's lymphoma--comparison of outcomes.
European journal of haematology. Supplementum 2005;(66):106-10.
2005: Axel Gossmann; Hans Theodor Eich; Andreas Engert; Andreas Josting; Rolf-Peter Müller; Volker Diehl; Klaus-Jürgen Lackner
CT and MR imaging in Hodgkin's disease--present and future.
European journal of haematology. Supplementum 2005;(66):83-9.
2005: Martin R Weihrauch; Oliver Manzke; Marc Beyer; Heinz Haverkamp; Volker Diehl; Heribert Bohlen; Juergen Wolf; Joachim L Schultze
Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor.
Cancer research 2005;65(13):5516-9.
2005: Daniel Re; Roman K Thomas; Karolin Behringer; Volker Diehl
From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential.
Blood 2005;105(12):4553-60.
2005: Hans Michael Kvasnicka; Hans Michael Kvasnicka; Volker Diehl
Bone marrow features of diagnostic impact in erythrocytosis.
Annals of hematology 2005;84(6):362-7.
2005: Hans Michael Kvasnicka; Hans Michael Kvasnicka; Volker Diehl
Bone marrow CD34+ progenitor cells in Philadelphia chromosome-negative chronic myeloproliferative disorders--a clinicopathological study on 575 patients.
Leukemia & lymphoma 2005;46(5):709-15.
2005: Hans Michael Kvasnicka; Hans Michael Kvasnicka; Volker Diehl
Standardization of bone marrow features--does it work in hematopathology for histological discrimination of different disease patterns?
Histology and histopathology 2005;20(2):633-44.
2005: Andreas Josting; Lucia Nogová; Jeremy Franklin; Jan-Peter Glossmann; Hans Theodor Eich; Markus Sieber; Thomas Schober; Heinz-Dietrich Boettcher; Ulrich Schulz; Rolf-Peter Müller; Volker Diehl; Andreas Engert
Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(7):1522-9.
2005: Hans Michael Kvasnicka; Hans Michael Kvasnicka; Volker Diehl
Initial (latent) polycythemia vera with thrombocytosis mimicking essential thrombocythemia.
Acta haematologica 2005;113(4):213-9.
2005: Hanns-Peter Knaebel; Angela Märten; Jan Schmidt; Katrin Hoffmann; C Seiler; Katja Lindel; Hubertus Schmitz-Winnenthal; Stefan Fritz; T Herrmann; H Goldschmidt; Robert Krempien; U Mansmann; Jürgen Debus; Volker Diehl; Markus W Büchler
Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma -- CapRI: study protocol [ISRCTN62866759].
BMC cancer 2005;5():37.
2005: Beate Klimm; Andreas Engert; Volker Diehl
First-line treatment of Hodgkin's lymphoma.
Current hematology reports 2005;4(1):15-22.
2005: Veronika Ballova; JU Rüffer; Heinz Haverkamp; Beate Pfistner; Hans Konrad Müller-Hermelink; Eckhart Dühmke; P Worst; M Wilhelmy; R Naumann; M Hentrich; Hans Theodor Eich; Andreas Josting; Markus Loeffler; Volker Diehl; Andreas Engert
A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(1):124-31.
2005: Andreas Josting; C Rudolph; MY Mapara; Jan-Peter Glossmann; M Sieniawski; M Sienawski; Markus Sieber; H H Kirchner; Bernd Dörken; D K Hossfeld; Jens Kisro; B Metzner; W E Berdel; Volker Diehl; Andreas Engert
Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(1):116-23.
2004: Eva-Maria Schneider; Emina Torlakovic; Albert Stühler; Volker Diehl; Hans Tesch; Bernd Giebel
The early transcription factor GATA-2 is expressed in classical Hodgkin's lymphoma.
The Journal of pathology 2004;204(5):538-45.
2004: Beate Klimm; Andreas Engert; Volker Diehl
Axillary swelling and a reduced general condition in a middle-aged man.
Nature clinical practice. Oncology 2004;1(1):51-4; quiz 1 p following 54.
2004: Martin R Weihrauch; Volker Diehl
Artificial sweeteners--do they bear a carcinogenic risk?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(10):1460-5.
2004: Hans Michael Kvasnicka; Hans Michael Kvasnicka; G Zerhusen; J Vardiman; Volker Diehl; M Luebbert; Annette Schmitt-Graeff
Acute panmyelosis with myelofibrosis: a clinicopathological study on 46 patients including histochemistry of bone marrow biopsies and follow-up.
Annals of hematology 2004;83(8):513-21.
2004: Karolin Behringer; Andreas Josting; P Schiller; Hans Theodor Eich; Henning Bredenfeld; Volker Diehl; Andreas Engert
Solid tumors in patients treated for Hodgkin's disease: a report from the German Hodgkin Lymphoma Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(7):1079-85.
2004: Roman K Thomas; Claudia Wickenhauser; Samir Tawadros; Volker Diehl; Ralf Küppers; Jürgen Wolf; Roland Schmitz
Mutational analysis of the IkappaBalpha gene in activated B cell-like diffuse large B-cell lymphoma.
British journal of haematology 2004;126(1):50-4.
2004: Claudia Heuser; Stefan Guhlke; Alexander Matthies; Hans Bender; Stefan Barth; Volker Diehl; Hinrich Abken; Andreas Hombach
Anti-CD30-scFv-Fc-IL-2 antibody-cytokine fusion protein that induces resting NK cells to highly efficient cytolysis of Hodgkin's lymphoma derived tumour cells.
International journal of cancer. Journal international du cancer 2004;110(3):386-94.
2004: Henning Bredenfeld; Jeremy Franklin; Lucia Nogova; Andreas Josting; S Fries; Volker Mailänder; Joachim Oertel; Volker Diehl; Andreas Engert
Severe pulmonary toxicity in patients with advanced-stage Hodgkin's disease treated with a modified bleomycin, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone, and gemcitabine (BEACOPP) regimen is probably related to the combination of gemcitabine and bleomycin: a report of the German Hodgkin's Lymphoma Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(12):2424-9.
2004: Hans Theodor Eich; Susanne Staar; Axel Gossmann; Andreas Engert; Jeremy Franklin; Markus Sieber; Barbara Krug; Volker Diehl; Klaus-Jürgen Lackner; Rolf-Peter Müller
The HD12 panel of the German Hodgkin Lymphoma Study Group (GHSG): a quality assurance program based on a multidisciplinary panel reviewing all patients' imaging.
American journal of clinical oncology 2004;27(3):279-84.
2004: Pia Hartmann; Ute Rehwald; Bernd Salzberger; Caspar Franzen; Volker Diehl
Current treatment strategies for patients with Hodgkin's lymphoma and HIV infection.
Expert review of anticancer therapy 2004;4(3):401-10.
2004: Roman K Thomas; Claudia Wickenhauser; Martin Hafner; Hans Tesch; Volker Diehl; Jürgen Wolf; Martina Vockerodt
Repeated clonal relapses in classical Hodgkin's lymphoma and the occurrence of a clonally unrelated diffuse large B cell non-Hodgkin lymphoma in the same patient.
Leukemia & lymphoma 2004;45(5):1065-9.
2004: Martin R Weihrauch; Peter Staib; Bettina Seiberlich; Martin Hoffmann; Volker Diehl; Hans Tesch
Phase I/II clinical study of topotecan and cytarabine in patients with myelodysplastic syndrome, chronic myelomonocytic leukemia and acute myeloid leukemia.
Leukemia & lymphoma 2004;45(4):699-704.
2004: A Herrmann-Frank; Volker Diehl
[Malignant lymphoma competence network].
Der Internist 2004;45(4):429-35.
2004: Hans Theodor Eich; Susanne Staar; Axel Gossmann; Katja Hansemann; Roman Skripnitchenko; Martin Kocher; Robert Semrau; Andreas Engert; Andreas Josting; Jeremy Franklin; Barbara Krug; Volker Diehl; Rolf-Peter Müller
Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group.
International journal of radiation oncology, biology, physics 2004;58(4):1121-7.
2004: Oana Brosteanu; Dirk Hasenclever; Markus Loeffler; Volker Diehl
Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin's disease.
Annals of hematology 2004;83(3):176-82.
2004: Christof Scheid; Karin Hermann; Gisela Kremer; Anja Holsing; Georg Heck; Michael Fuchs; Dirk Waldschmidt; Hans-Joachim Herrmann; Dietmar Söhngen; Volker Diehl; Achim Schwenk
Randomized, double-blind, controlled study of glycyl-glutamine-dipeptide in the parenteral nutrition of patients with acute leukemia undergoing intensive chemotherapy.
Nutrition (Burbank, Los Angeles County, Calif.) 2004;20(3):249-54.
2004: Hans Theodor Eich; Rolf-Peter Müller; Angelika Schneeweiss; Katja Hansemann; Robert Semrau; Normann Willich; Christian Rübe; Susanne Sehlen; Margit Hinkelbein; Volker Diehl
Initiation of a teleradiotherapeutic network for patients in German lymphoma studies.
International journal of radiation oncology, biology, physics 2004;58(3):805-8.
2004: Oliver A Cornely; Thomas Wicke; Harald Seifert; Ullrich Bethe; Martin Schwonzen; Dietmar Reichert; Andrew J Ullmann; Meinolf Karthaus; Kai Breuer; Bernd Salzberger; Volker Diehl; Gerd Fätkenheuer
Once-daily oral levofloxacin monotherapy versus piperacillin/tazobactam three times a day: a randomized controlled multicenter trial in patients with febrile neutropenia.
International journal of hematology 2004;79(1):74-8.
2004: Andreas Josting; Karolin Behringer; Andreas Engert; Volker Diehl
[Modern pharmacotherapy of Hodgkin disease].
Der Internist 2004;45(1):93-101.
2004: Hans Michael Kvasnicka; Hans Michael Kvasnicka; Annette Schmitt-Gräff; R Hülsemann; Volker Diehl
Therapy-related changes of the bone marrow in chronic idiopathic myelofibrosis.
Histology and histopathology 2004;19(1):239-50.
2004: Volker Diehl; Roman K Thomas; Daniel Re
Part II: Hodgkin's lymphoma--diagnosis and treatment.
The lancet oncology 2004;5(1):19-26.
2004: Roman K Thomas; Daniel Re; Jürgen Wolf; Volker Diehl
Part I: Hodgkin's lymphoma--molecular biology of Hodgkin and Reed-Sternberg cells.
The lancet oncology 2004;5(1):11-8.
2003: Roman K Thomas; Volker Diehl
Unhappy neighbourhood: spatial genome organisation and lymphomagenesis in B cells.
Lancet 2003;362(9399):1868-70.
2003: Peter Borchmann; John F Treml; Hinrich Hansen; Claudia Gottstein; Roland Schnell; Oliver Staak; Hui-fen Zhang; Thomas Davis; Tibor Keler; Volker Diehl; Robert F Graziano; Andreas Engert
The human anti-CD30 antibody 5F11 shows in vitro and in vivo activity against malignant lymphoma.
Blood 2003;102(10):3737-42.
2003: Beate Pfistner; C Mehl; M Klöss; Markus Loeffler; A Herrmann-Frank; Volker Diehl
[Quality standards and their assurance for study centers in the competence network malignant lymphoma].
Klinische Pädiatrie 2003;215(6):341-4.
2003: Hans Michael Kvasnicka; Hans Michael Kvasnicka; Annette Schmitt-Graeff; Volker Diehl
Bone marrow histopathology following cytoreductive therapy in chronic idiopathic myelofibrosis.
Histopathology 2003;43(5):470-9.
2003: JU Rüffer; Henning Flechtner; P Tralls; Andreas Josting; Markus Sieber; Bernd Lathan; Volker Diehl
Fatigue in long-term survivors of Hodgkin's lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG).
European journal of cancer (Oxford, England : 1990) 2003;39(15):2179-86.
2003: Pia Hartmann; Ute Rehwald; Bernd Salzberger; Caspar Franzen; Markus Sieber; Andrej Wöhrmann; Volker Diehl
BEACOPP therapeutic regimen for patients with Hodgkin's disease and HIV infection.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(10):1562-9.
2003: Andreas Engert; Petra Schiller; Andreas Josting; Richard Herrmann; Peter Koch; Markus Sieber; Friederike Boissevain; Maike de Wit; Jorg Mezger; Eckhart Duhmke; Normann Willich; Rolf-Peter Muller; Bernhard F Schmidt; Helmut Renner; H Konrad Muller-Hermelink; Beate Pfistner; Jürgen Wolf; Dirk Hasenclever; Markus Loffler; Volker Diehl
Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(19):3601-8.
2003: Andreas Josting; Sabine Wiedenmann; Jeremy Franklin; Michael May; Markus Sieber; Juergen Wolf; Andreas Engert; Volker Diehl
Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(18):3440-6.
2003: Claudia Heuser; Volker Diehl; Hinrich Abken; Andreas Hombach
Anti-CD30-IL-12 antibody-cytokine fusion protein that induces IFN-gamma secretion of T cells and NK cell-mediated lysis of Hodgkin's lymphoma-derived tumor cells.
International journal of cancer. Journal international du cancer 2003;106(4):545-52.
2003: Jan-Peter Glossmann; Jan Oliver Staak; Claudia Wickenhauser; Volker Diehl; Andreas Josting
Extramedullary acute myeloid leukemia (granulocytic sarcoma) with arm paresis, maculopapular exanthema and organ involvement.
Leukemia & lymphoma 2003;44(9):1619-21.
2003: Jan Oliver Staak; Jan-Peter Glossmann; Johannes Markus Esser; Volker Diehl; Holger Mietz; Andreas Josting
Thalidomide for systemic capillary leak syndrome.
The American journal of medicine 2003;115(4):332-4.
2003: Andreas Josting; Volker Diehl
Current treatment strategies in early stage Hodgkin's disease.
Current treatment options in oncology 2003;4(4):297-305.
2003: Jan-Peter Glossmann; Andreas Engert; G Wassmer; Henning Flechtner; Y Ko; C Rudolph; B Metzner; Bernd Dörken; S Wiedenmann; Volker Diehl; Andreas Josting
Recombinant human erythropoietin, epoetin beta, in patients with relapsed lymphoma treated with aggressive sequential salvage chemotherapy--results of a randomized trial.
Annals of hematology 2003;82(8):469-75.
2003: Ulrich Rueffer; Markus Sieber; M Stemberg; A Gossmann; Andreas Josting; T Koch; FJ Grotenhermen; Volker Diehl
Spleen involvement in Hodgkin's lymphoma: assessment and risk profile.
Annals of hematology 2003;82(7):390-6.
2003: Volker Diehl; Jeremy Franklin; Michael Pfreundschuh; Bernd Lathan; Ursula Paulus; Dirk Hasenclever; Hans Tesch; Richard Herrmann; Bernd Dörken; Hans Konrad Müller-Hermelink; Eckhart Dühmke; Markus Loeffler
Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.
The New England journal of medicine 2003;348(24):2386-95.
2003: Hans Michael Kvasnicka; Hans Michael Kvasnicka; Annette Schmitt-Graeff; Volker Diehl
Dynamics of fibrosis in chronic idiopathic (primary) myelofibrosis during therapy: a follow-up study on 309 patients.
Leukemia & lymphoma 2003;44(6):949-53.
2003: Daniel Re; Petr Starostik; Nadia Massoudi; Andrea Staratschek-Jox; Volker Dries; Roman K Thomas; Volker Diehl; Jürgen Wolf
Allelic losses on chromosome 6q25 in Hodgkin and Reed Sternberg cells.
Cancer research 2003;63(10):2606-9.
2003: Sabine von Wasielewski; Jeremy Franklin; Robert Fischer; Klaus Hübner; Martin-Leo Hansmann; Volker Diehl; Axel Georgii; Reinhard von Wasielewski
Nodular sclerosing Hodgkin disease: new grading predicts prognosis in intermediate and advanced stages.
Blood 2003;101(10):4063-9.
2003: Markus Sieber; Henning Bredenfeld; Andreas Josting; T Reineke; Ulrich Rueffer; T Koch; R Naumann; Friederike Boissevain; Peter Koch; P Worst; M Soekler; Hans Theodor Eich; Hans Konrad Müller-Hermelink; Jeremy Franklin; Ursula Paulus; Jürgen Wolf; Andreas Engert; Volker Diehl
14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(9):1734-9.
2003: Ines Schwering; Andreas Bräuninger; Verena Distler; Julia Jesdinsky; Volker Diehl; Martin-Leo Hansmann; Klaus Rajewsky; Ralf Küppers
Profiling of Hodgkin's lymphoma cell line L1236 and germinal center B cells: identification of Hodgkin's lymphoma-specific genes.
Molecular medicine (Cambridge, Mass.) 2003;9(3-4):85-95.
2003: Ines Schwering; Andreas Bräuninger; Ulf Klein; Berit Jungnickel; Marianne Tinguely; Volker Diehl; Martin-Leo Hansmann; Riccardo Dalla-Favera; Klaus Rajewsky; Ralf Küppers
Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
Blood 2003;101(4):1505-12.
2003: Jan Oliver Staak; Markus Dietlein; Andreas Engert; Martin R Weihrauch; Klaus Schomäcker; Th Fischer; Wolfgang Eschner; Peter Borchmann; Volker Diehl; Harald Schicha; Roland Schnell
[Hodgkin's lymphoma in nuclear medicine: diagnostic and therapeutic aspects].
Nuklearmedizin. Nuclear medicine 2003;42(1):19-24.
2003: Ute Rehwald; Holger Schulz; Marcel Reiser; Markus Sieber; Jan Oliver Staak; Franck Morschhauser; Christoph Driessen; Thomas Rudiger; Konrad Muller-Hermelink; Volker Diehl; Andreas Engert
Treatment of relapsed CD20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study Group.
Blood 2003;101(2):420-4.
2003: Hans Theodor Eich; Rolf-Peter Müller; Sascha Ansén; Andreas Josting; Andreas Engert; Katja Hansemann; Beate Pfistner; Jürgen Wolf; Normann Willich; Volker Diehl
[New therapeutic strategies for Hodgkin lymphoma in cooperation of radiation oncology and medical oncology].
Röntgenpraxis; Zeitschrift für radiologische Technik 2003;55(3):114-24.
2003: Volker Diehl; Harald Stein; Michael Hummel; Raphael Zollinger; Joseph Michael Connors
Hodgkin's lymphoma: biology and treatment strategies for primary, refractory, and relapsed disease.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2003;():225-47.
2003: Martin R Weihrauch; Markus Dietlein; Harald Schicha; Volker Diehl; Hans Tesch
Prognostic significance of 18F-fluorodeoxyglucose positron emission tomography in lymphoma.
Leukemia & lymphoma 2003;44(1):15-22.
2003: Hans Michael Kvasnicka; Hans Michael Kvasnicka; Annette Schmitt-Graeff; Volker Diehl; Norbert Niederle; Hans-Eckart Schaefer
Impact of bone marrow morphology on multivariate risk classification in chronic myelogenous leukemia.
Acta haematologica 2003;109(1):53-6.
2002: Sascha Ansén; Markus Sieber; K Wingbermühle; Andreas Josting; Volker Diehl
[Current therapeutic strategies in Hodgkin lymphoma].
Der Internist 2002;43(12):1544-50.
2002: S Wilde; Alexander Jetter; M Zaigier; Stephan Rietbrock; H Menzel; M Sieber; H Tesch; Georg Hempel; Dagmar Busse; Matthias Schwab; Stefanie Reif; Ulrich Jaehde; Volker Diehl; Uwe Fuhr
Population pharmacokinetics of cyclophosphamide, doxorubicin and etoposide in 30 patients with BEACOPP chemotherapy.
International journal of clinical pharmacology and therapeutics 2002;40(12):586-8.
2002: Martina Vockerodt; Gazanfer Belge; Martin Hafner; Johannes Irsch; Reiner Siebert; Hans Tesch; Volker Diehl; Jürgen Wolf; Jörn Bullerdiek; Andrea Staratschek-Jox
An unbalanced translocation involving chromosome 14 is the probable cause for loss of potentially functional rearranged immunoglobulin heavy chain genes in the Epstein-Barr virus-positive Hodgkin's lymphoma-derived cell line L591.
British journal of haematology 2002;119(3):640-6.
2002: Anke S Krause; Martin R Weihrauch; Udo Bode; Gudrun Fleischhack; Thomas Elter; Theodor Heuer; Andreas Engert; Volker Diehl; Andreas Josting
Carboxypeptidase-G2 rescue in cancer patients with delayed methotrexate elimination after high-dose methotrexate therapy.
Leukemia & lymphoma 2002;43(11):2139-43.
2002: Martin R Weihrauch; Edmund Skibowski; Thomas Christian Koslowsky; Wilfried Voiss; Daniel Re; Ferdinand Kuhn-Regnier; Carolin Bannwarth; Michel Siedek; Volker Diehl; Heribert Bohlen
Immunomagnetic enrichment and detection of micrometastases in colorectal cancer: correlation with established clinical parameters.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(21):4338-43.
2002: Holger Schulz; Saskia Karina Klein; Ute Rehwald; Marcel Reiser; Axel Hinke; Wolfgang Knauf; Walter Aulitzky; Manfred Hensel; Michael Herold; Dieter Huhn; Michael Hallek; Volker Diehl; Andreas Engert
Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia.
Blood 2002;100(9):3115-20.
2002: Peter Borchmann; Roland Schnell; Irene Fuss; Oliver Manzke; Thomas Davis; Lionel D Lewis; Detlev Behnke; Claudia Wickenhauser; Petra Schiller; Volker Diehl; Andreas Engert
Phase 1 trial of the novel bispecific molecule H22xKi-4 in patients with refractory Hodgkin lymphoma.
Blood 2002;100(9):3101-7.
2002: Jan Oliver Staak; Jan-Peter Glossmann; Volker Diehl; Andreas Josting
[Hepatitis-C-virus-associated cryoglobulinemia. Pathogenesis, diagnosis and treatment].
Medizinische Klinik (Munich, Germany : 1983) 2002;97(10):601-8.
2002: Andreas Josting; C Rudolph; Marcel Reiser; MY Mapara; Markus Sieber; H H Kirchner; Bernd Dörken; D K Hossfeld; Volker Diehl; Andreas Engert
Time-intensified dexamethasone/cisplatin/cytarabine: an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(10):1628-35.
2002: Jens M Chemnitz; Andreas Draube; Christof Scheid; Peter Staib; Armin Schulz; Volker Diehl; Dietmar Söhngen
Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab.
American journal of hematology 2002;71(2):105-8.
2002: Hans Michael Kvasnicka; Hans Michael Kvasnicka; Annette Schmitt-Graeff; Rudolph Zankovich; Volker Diehl
Follow-up examinations including sequential bone marrow biopsies in essential thrombocythemia (ET): a retrospective clinicopathological study of 120 patients.
American journal of hematology 2002;70(4):283-91.
2002: Jan-Peter Glossmann; Andreas Josting; Volker Diehl
New treatments for Hodgkin's disease.
Current treatment options in oncology 2002;3(4):283-90.
2002: Norbert Schmitz; Beate Pfistner; Michael Sextro; Markus Sieber; Angelo M Carella; Matthias Haenel; Friederike Boissevain; Reinhart Zschaber; Peter Müller; Hartmut Kirchner; Andreas Lohri; Susanne Decker; Bettina Koch; Dirk Hasenclever; Anthony H Goldstone; Volker Diehl
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial.
Lancet 2002;359(9323):2065-71.
2002: Dimitris Voliotis; Volker Diehl
Challenges in treating hematologic malignancies.
Seminars in oncology 2002;29(3 Suppl 8):30-9.
2002: Roland Schnell; Oliver Staak; Peter Borchmann; Christine Schwartz; Bärbel Matthey; Hinrich Hansen; John Schindler; Victor Ghetie; Ellen S Vitetta; Volker Diehl; Andreas Engert
A Phase I study with an anti-CD30 ricin A-chain immunotoxin (Ki-4.dgA) in patients with refractory CD30+ Hodgkin's and non-Hodgkin's lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(6):1779-86.
2002: Hans Michael Kvasnicka; Hans Michael Kvasnicka; Rudolph Zankovich; Volker Diehl
Early-stage idiopathic (primary) myelofibrosis--current issues of diagnostic features.
Leukemia & lymphoma 2002;43(5):1035-41.
2002: T Pfitzner; Marcel Reiser; Stefan Barth; Peter Borchmann; Holger Schulz; Timo Schinköthe; F Oberhäuser; J Wessels; Mehmet K Tur; Volker Diehl; Andreas Engert
Quantitative molecular monitoring of residual tumor cells in chronic lymphocytic leukemia.
Annals of hematology 2002;81(5):258-66.
2002: R Walshe; A Herrmann-Frank; Volker Diehl
[Center of excellence, cancer center, competence network: confusion of terminology?].
Deutsche medizinische Wochenschrift (1946) 2002;127(17):913-4.
2002: Daniel Re; Claudia Wickenhauser; Tahamtan Ahmadi; E Buchdunger; Matthias Kochanek; Volker Diehl; Jürgen Wolf
Preclinical evaluation of the antiproliferative potential of STI571 in Hodgkin's disease.
British journal of cancer 2002;86(8):1333-5.
2002: M Reiser; Andreas Josting; M Soltani; Peter Staib; B Salzberger; Volker Diehl; Andreas Engert
T-cell non-Hodgkin's lymphoma in adults: clinicopathological characteristics, response to treatment and prognostic factors.
Leukemia & lymphoma 2002;43(4):805-11.
2002: Roman K Thomas; Anne Kallenborn; Claudia Wickenhauser; Joachim L Schultze; Andreas Draube; Martina Vockerodt; Daniel Re; Volker Diehl; Jürgen Wolf
Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells.
The American journal of pathology 2002;160(4):1521-8.
2002: Markus Sieber; Hans Tesch; Beate Pfistner; Ulrich Rueffer; Bernd Lathan; Oana Brosteanu; Ursula Paulus; Tina Koch; Michael Pfreundschuh; Markus Loeffler; Andreas Engert; Andreas Josting; Jürgen Wolf; Dirk Hasenclever; Jeremy Franklin; Eckhart Duehmke; Axel Georgii; Klaus-Peter Schalk; Hartmut Kirchner; Gottfried Doelken; Reinhold Munker; Peter Koch; Richard Herrmann; richard greil; Anna Paola Anselmo; Volker Diehl
Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(2):476-84.
2002: Daniel Re; Lena Benenson; Claudia Wickenhauser; Petr Starostik; Andrea Staratschek-Jox; Hans Konrad Müller-Hermelink; Volker Diehl; Jürgen Wolf
Proficient mismatch repair protein expression in Hodgkin and Reed Sternberg cells.
International journal of cancer. Journal international du cancer 2002;97(2):205-10.
2002: Martin R Weihrauch; Edmund Skibowski; Andreas Draube; Andrea Geller; Hans Tesch; Volker Diehl; Heribert Bohlen
Immunomagnetic enrichment and detection of isolated tumor cells in bone marrow of patients with epithelial malignancies.
Clinical & experimental metastasis 2002;19(7):617-21.
2002: Roman K Thomas; Daniel Re; Thomas Zander; Jürgen Wolf; Volker Diehl
Epidemiology and etiology of Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13 Suppl 4():147-52.
2002: Jeremy Franklin; Volker Diehl
Current clinical trials for the treatment of advanced-stage Hodgkin's disease: BEACOPP.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13 Suppl 1():98-101.
2002: Patrice Carde; serge koscielny; Jeremy Franklin; U Axdorph; John M M Raemaekers; Volker Diehl; Berthe M P Aleman; Oana Brosteanu; Dirk Hasenclever; Odile Oberlin; N Bonvin; M Björkholm
Early response to chemotherapy: a surrogate for final outcome of Hodgkin's disease patients that should influence initial treatment length and intensity?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13 Suppl 1():86-91.
2002: Daniel Re; Thomas Zander; Volker Diehl; Jürgen Wolf
Genetic instability in Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13 Suppl 1():19-22.
2002: Andreas Josting; J M Raemakers; Volker Diehl; Andreas Engert
New concepts for relapsed Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13 Suppl 1():117-21.
2002: Andreas Josting; Andreas Engert; Volker Diehl; George P Canellos
Prognostic factors and treatment outcome in patients with primary progressive and relapsed Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13 Suppl 1():112-6.
2002: S Wiedenmann; Jürgen Wolf; Volker Diehl
An overview of the Fifth International Symposium on Hodgkin's lymphoma: recent advances in basic and clinical research.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13 Suppl 1():1-3.
2002: Martin R Weihrauch; Daniel Re; S Bischoff; Markus Dietlein; Klemens Scheidhauer; Barbara Krug; F Textoris; Sascha Ansén; Jeremy Franklin; Heribert Bohlen; Jürgen Wolf; Harald Schicha; Volker Diehl; Hans Tesch
Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's disease.
Annals of hematology 2002;81(1):20-5.
2002: Andreas Josting; Jeremy Franklin; Michael May; Peter Koch; Maria K Beykirch; Juergen Heinz; Christian Rudolph; Volker Diehl; Andreas Engert
New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(1):221-30.
2001: Hans Michael Kvasnicka; Hans Michael Kvasnicka; Annette Schmitt-Graeff; D Goekce; Volker Diehl; Rudolph Zankovich; Hans-Eckart Schaefer
Therapy-related changes of CD34+ progenitor cells in chronic myeloid leukemia: a morphometric study on sequential trephine biopsies.
Journal of hematotherapy & stem cell research 2001;10(6):827-36.
2001: Martin R Weihrauch; Volker Diehl; Heribert Bohlen
[Artificial sweeteners--are they potentially carcinogenic?].
Medizinische Klinik (Munich, Germany : 1983) 2001;96(11):670-5.
2001: Martin R Weihrauch; Daniel Re; Klemens Scheidhauer; Sascha Ansén; Markus Dietlein; S Bischoff; Heribert Bohlen; Jürgen Wolf; Harald Schicha; Volker Diehl; Hans Tesch
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease.
Blood 2001;98(10):2930-4.
2001: Martin Kornacker; U Schlattner; Theo Wallimann; Michael verneris; Robert S Negrin; B Kornacker; Andrea Staratschek-Jox; Volker Diehl; Jürgen Wolf
Hodgkin disease-derived cell lines expressing ubiquitous mitochondrial creatine kinase show growth inhibition by cyclocreatine treatment independent of apoptosis.
International journal of cancer. Journal international du cancer 2001;94(4):513-9.
2001: Daniel Re; Andrea Staratschek-Jox; U Holtick; Volker Diehl; Jürgen Wolf
Deregulation of immunoglobulin gene transcription in the Hodgkin-Reed Sternberg cell line L1236.
British journal of haematology 2001;115(2):326-8.
2001: Martin R Weihrauch; K Rabe; Matthias Kochanek; Hans Tesch; Volker Diehl; Jürgen Wolf
[Factitious disorders. Hematologic, neurologic and dermatologic symptoms in a physician with factitious disorder].
Medizinische Klinik (Munich, Germany : 1983) 2001;96(9):555-60.
2001: Ulrich Rueffer; Kai Breuer; Andreas Josting; Bernd Lathan; Markus Sieber; Oliver Manzke; FJ Grotenhermen; Hans Tesch; Henning Bredenfeld; Peter Koch; Hiltrud Nisters-Backes; Jürgen Wolf; Andreas Engert; Volker Diehl
Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(9):1307-11.
2001: Martin Hafner; U Holtick; Martina Vockerodt; Tahamtan Ahmadi; B Haier; I Behrmann; P C Heinrich; Volker Diehl; Hans Tesch
STAT3 is constitutively activated in Hodgkin cell lines.
Blood 2001;98(3):762-70.
2001: Marcel Reiser; Henning Bredenfeld; Andreas Engert; Volker Diehl
The role of ifosfamide in the treatment of relapsed and refractory lymphoma.
European journal of haematology. Supplementum 2001;64():37-40.
2001: Jens M Chemnitz; A Schulz; Volker Diehl; Dietmar Söhngen
[Thrombotic-thrombocytopenic purpura (Moschcowitz syndrome)].
Medizinische Klinik (Munich, Germany : 1983) 2001;96(6):343-50.
2001: Hans Michael Kvasnicka; Hans Michael Kvasnicka; Annette Schmitt-Graeff; Volker Diehl; Rudolph Zankovich; Norbert Niederle; Lutz-Dietrich Leder; Hans-Eckart Schaefer
Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic-phase Ph(1+) chronic myelogenous leukemia: a multicenter trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(12):2994-3009.
2001: Andrea Rubbert; Volker Diehl
[New approaches to treatment in immunology with monoclonal antibodies].
Der Internist 2001;42(6):843, 846-53.
2001: Roland Schnell; W Hiddemann; Volker Diehl; Andreas Engert
[Clinical use of monoclonal antibodies in malignant lymphomas].
Der Internist 2001;42(6):815-6, 819-26.
2001: Andreas Engert; Volker Diehl
[Therapy with monoclonal antibodies].
Der Internist 2001;42(6):801-2.
2001: Eckhart Dühmke; Jeremy Franklin; Michael Pfreundschuh; Susanne Sehlen; Normann Willich; Ursula Rühl; Rolf-Peter Müller; P Lukas; A Atzinger; Ursula Paulus; Bernd Lathan; U Rüffer; Markus Sieber; Jürgen Wolf; Andreas Engert; Axel Georgii; Susanne Staar; Richard Herrmann; M Beykirch; Hartmut Kirchner; A Emminger; richard greil; E Fritsch; Peter Koch; A Drochtert; Oana Brosteanu; Dirk Hasenclever; Markus Loeffler; Volker Diehl
Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: long-term results of a randomized trial of radiotherapy alone.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(11):2905-14.
2001: Johannes Irsch; Jürgen Wolf; Hans Tesch; Volker Diehl; Andreas Radbruch; Andrea Staratschek-Jox
Class switch recombination was specifically targeted to immunoglobulin (Ig)G4 or IgA in Hodgkin's disease-derived cell lines.
British journal of haematology 2001;113(3):785-93.
2001: Peter Borchmann; Roland Schnell; R Knippertz; Jan Oliver Staak; Gabriella Camboni; A Bernareggi; Kai Hübel; Peter Staib; A Schulz; Volker Diehl; Andreas Engert
Phase I study of BBR 2778, a new aza-anthracenedione, in advanced or refractory non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(5):661-7.
2001: Daniel Re; E Benenson; Marc Beyer; O Gresch; Andreas Draube; Volker Diehl; Jürgen Wolf
Cell fusion is not involved in the generation of giant cells in the Hodgkin-Reed Sternberg cell line L1236.
American journal of hematology 2001;67(1):6-9.
2001: Michael Pfreundschuh; Dirk Hasenclever; Markus Loeffler; G Ehninger; Norbert Schmitz; Hartmut Kirchner; Peter Koch; Bernd Lathan; Ulrich Rueffer; Michael Sextro; Jeremy Franklin; Hans Tesch; Volker Diehl
Dose escalation of cytotoxic drugs using haematopoietic growth factors: a randomized trial to determine the magnitude of increase provided by GM-CSF.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(4):471-7.
2001: Hans Michael Kvasnicka; Hans Michael Kvasnicka; Rudolph Zankovich; Volker Diehl
The value of bone marrow histology in differentiating between early stage Polycythemia vera and secondary (reactive) Polycythemias.
Haematologica 2001;86(4):368-74.
2001: Ulrich Rueffer; Andreas Josting; Jeremy Franklin; Michael May; Markus Sieber; Kai Breuer; Andreas Engert; Volker Diehl
Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(7):2026-32.
2001: Hans Michael Kvasnicka; Hans Michael Kvasnicka; Rudolph Zankovich; Volker Diehl
Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosis.
Annals of hematology 2001;80(3):160-5.
2001: Daniel Re; Markus Müschen; Tahamtan Ahmadi; Claudia Wickenhauser; Andrea Staratschek-Jox; U Holtick; Volker Diehl; Jürgen Wolf
Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells.
Cancer research 2001;61(5):2080-4.
2001: Hans Michael Kvasnicka; Hans Michael Kvasnicka; Annette Schmitt-Graeff; Volker Diehl; Rudolph Zankovich; Norbert Niederle; Lutz-Dietrich Leder; Hans-Eckart Schaefer
Prognostic impact of bone marrow erythropoietic precursor cells and myelofibrosis at diagnosis of Ph1+ chronic myelogenous leukaemia--a multicentre study on 495 patients.
British journal of haematology 2001;112(3):727-39.
2001: Oliver Manzke; Hans Tesch; Johann Lorenzen; Volker Diehl; Heribert Bohlen
Locoregional treatment of low-grade B-cell lymphoma with CD3xCD19 bispecific antibodies and CD28 costimulation. II. Assessment of cellular immune responses.
International journal of cancer. Journal international du cancer 2001;91(4):516-22.
2001: Oliver Manzke; Hans Tesch; Peter Borchmann; Jürgen Wolf; K Lackner; Axel Gossmann; Volker Diehl; Heribert Bohlen
Locoregional treatment of low-grade B-cell lymphoma with CD3xCD19 bispecific antibodies and CD28 costimulation. I. Clinical phase I evaluation.
International journal of cancer. Journal international du cancer 2001;91(4):508-15.
2001: Andrea Staratschek-Jox; Roman K Thomas; Thomas Zander; Nadia Massoudi; Martin Kornacker; Jörn Bullerdiek; Christa Fonatsch; Volker Diehl; Jürgen Wolf
Loss of heterozygosity in the Hodgkin-Reed Sternberg cell line L1236.
British journal of cancer 2001;84(3):381-7.
2001: Sascha Ansén; Andreas Engert; Jürgen Wolf; Markus Sieber; Ursula Paulus; Volker Diehl
[German Hodgkin's Lymphoma Study Group].
Onkologie 2001;24 Suppl 1():35-48.
2001: Andreas Draube; R Pfister; Martina Vockerodt; S Schuster; Martin Hafner; Volker Diehl; Hans Tesch
Immunomagnetic enrichment of CD138 positive cells from weakly infiltrated myeloma patients samples enables the determination of the tumor clone specific IgH rearrangement.
Annals of hematology 2001;80(2):83-9.
2001: Oliver A Cornely; Ullrich Bethe; Bernd Salzberger; Caspar Franzen; Pia Hartmann; T Steinmetz; Gerd Fätkenheuer; Harald Seifert; Volker Diehl; Martin Schrappe
Randomized controlled monocentric comparison of once daily ceftriaxone with tobramycin and cefotaxime three times daily with tobramycin in neutropenic fever.
Annals of hematology 2001;80(2):103-8.
2001: Hans Michael Kvasnicka; Hans Michael Kvasnicka; Annette Schmitt-Graeff; Volker Diehl; Norbert Niederle; Hans-Eckart Schaefer
Bone marrow histopathology predicting blast crisis in chronic myeloid leukemia.
Acta haematologica 2001;105(4):244-6.
2001: Oliver Manzke; O Russello; C Leenen; Volker Diehl; Heribert Bohlen; Frank Berthold
Immunotherapeutic strategies in neuroblastoma: antitumoral activity of deglycosylated Ricin A conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies.
Medical and pediatric oncology 2001;36(1):185-9.
2001: Oliver A Cornely; Jens M Chemnitz; Hans-Georg Brochhagen; Karin Lemmer; H Schütt; Dietmar Söhngen; Peter Staib; Claudia Wickenhauser; Volker Diehl; Kathrin Tintelnot
Disseminated Neocosmospora vasinfecta infection in a patient with acute nonlymphocytic leukemia.
Emerging infectious diseases 2001;7(1):149-52.
2001: Hans Michael Kvasnicka; Hans Michael Kvasnicka; K Muehlhausen; S Walter; Rudolph Zankovich; Volker Diehl
Polycythemia rubra vera versus secondary polycythemias. A clinicopathological evaluation of distinctive features in 199 patients.
Pathology, research and practice 2001;197(2):77-84.
2000: Markus Müschen; Daniel Re; Berit Jungnickel; Volker Diehl; Klaus Rajewsky; Ralf Küppers
Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reaction.
The Journal of experimental medicine 2000;192(12):1833-40.
2000: Kai Hübel; Georg Mansmann; HH Schäfer; F Oberhäuser; Volker Diehl; Andreas Engert
Increase of anti-inflammatory cytokines in patients with esophageal cancer after perioperative treatment with G-CSF.
Cytokine 2000;12(12):1797-800.
2000: Hans Michael Kvasnicka; Hans Michael Kvasnicka; Rudolph Zankovich; Volker Diehl
Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.
Haematologica 2000;85(11):1126-34.
2000: Markus Müschen; Daniel Re; Andreas Bräuninger; Jürgen Wolf; Martin-Leo Hansmann; Volker Diehl; Ralf Küppers; Klaus Rajewsky
Somatic mutations of the CD95 gene in Hodgkin and Reed-Sternberg cells.
Cancer research 2000;60(20):5640-3.
2000: Andreas Hombach; C Schneider; D Sent; D Koch; Ralph A Willemsen; Volker Diehl; Wolfgang Kruis; Reinder L H Bolhuis; C Pohl; Hinrich Abken
An entirely humanized CD3 zeta-chain signaling receptor that directs peripheral blood t cells to specific lysis of carcinoembryonic antigen-positive tumor cells.
International journal of cancer. Journal international du cancer 2000;88(1):115-20.
2000: Volker Diehl; I Schütt; R Walshe
[Publisher fraud. The publication of falsified medical research results].
Deutsche medizinische Wochenschrift (1946) 2000;125(38):1112-4.
2000: Christoph Engel; Markus Loeffler; S Schmitz; H Tesch; Volker Diehl
Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group (GHSG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(9):1105-14.
2000: Jens M Chemnitz; M Fuchs; W Blau; Pia Hartmann; Claudia Wickenhauser; Christof Scheid; Armin Schulz; Volker Diehl; Dietmar Söhngen
Fatal thrombotic thrombocytopenic purpura as a rare complication following allogeneic stem cell transplantation.
Annals of hematology 2000;79(9):527-9.
2000: Ioannis Anagnostopoulos; Martin-Leo Hansmann; K Franssila; M Harris; N L Harris; E S Jaffe; J Han; J M van Krieken; S Poppema; Teresa Marafioti; Jeremy Franklin; Michael Sextro; Volker Diehl; Harald Stein
European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes.
Blood 2000;96(5):1889-99.
2000: Jan-Peter Glossmann; O Schliebusch; Volker Diehl; R Walshe
["Lean management" in hospitals: potentials and limitations].
Medizinische Klinik (Munich, Germany : 1983) 2000;95(8):470-3.
2000: Andreas Josting; Ulrich Rueffer; Jeremy Franklin; Markus Sieber; Volker Diehl; Andreas Engert
Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study Group.
Blood 2000;96(4):1280-6.
2000: Andreas Müller; R Bialek; Gerd Fätkenheuer; Bernd Salzberger; Volker Diehl; Caspar Franzen
Detection of Isospora belli by polymerase chain reaction using primers based on small-subunit ribosomal RNA sequences.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2000;19(8):631-4.
2000: D Benedek; M Kiehl; Andreas Draube; Jens M Chemnitz; Volker Diehl; Dietmar Söhngen
Atypical chronic myeloid leukaemia with trisomy 21 mosaicism as a sole chromosomal abnormality.
Leukemia & lymphoma 2000;38(5-6):639-44.
2000: Caspar Franzen; Andreas Müller; R Bialek; Volker Diehl; Bernd Salzberger; Gerd Fätkenheuer
Taxonomic position of the human intestinal protozoan parasite Isospora belli as based on ribosomal RNA sequences.
Parasitology research 2000;86(8):669-76.
2000: G Röhrig; Heiko Kilter; Dirk J Beuckelmann; A Kröner; Christof Scheid; Volker Diehl; Dietmar Söhngen
Congenital dyserythropoietic anemia type III associated with congenital atrioseptal defect has led to severe cardiac problems in a 32-year-old patient.
American journal of hematology 2000;64(4):314-6.
2000: K Breuer; Volker Diehl; U Rüffer
[Long-term toxic sequelae of the treatment of Hodgkin's disease].
Medizinische Klinik (Munich, Germany : 1983) 2000;95(7):378-84.
2000: A Santoro; Henning Bredenfeld; liliana devizzi; Hans Tesch; Valeria Bonfante; Simonetta Viviani; F Fiedler; H S Parra; C Benoehr; M Pacini; Gianni Bonadonna; Volker Diehl
Gemcitabine in the treatment of refractory Hodgkin's disease: results of a multicenter phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(13):2615-9.
2000: Hans Michael Kvasnicka; Hans Michael Kvasnicka; Annette Schmitt-Graeff; S Bundschuh; T Biermann; Gernot Roessler; M Wasmus; Volker Diehl; Rudolph Zankovich; Hans-Eckart Schaefer
Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features.
American journal of clinical pathology 2000;114(1):57-65.
2000: Gerd Fätkenheuer; K Hell; Axel Roers; Volker Diehl; Bernd Salzberger
Spontaneous regression of HIV associated T-cell non-Hodgkin's lymphoma with highly active antiretroviral therapy.
European journal of medical research 2000;5(6):236-40.
2000: Stefan Barth; Michael Huhn; Bärbel Matthey; Samir Tawadros; Roland Schnell; Timo Schinköthe; Volker Diehl; Andreas Engert
Ki-4(scFv)-ETA', a new recombinant anti-CD30 immunotoxin with highly specific cytotoxic activity against disseminated Hodgkin tumors in SCID mice.
Blood 2000;95(12):3909-14.
2000: Andreas Hombach; Claudia Heuser; M Gerken; B Fischer; K Lewalter; Volker Diehl; C Pohl; Hinrich Abken
T cell activation by recombinant FcepsilonRI gamma-chain immune receptors: an extracellular spacer domain impairs antigen-dependent T cell activation but not antigen recognition.
Gene therapy 2000;7(12):1067-75.
2000: Stefan Barth; Michael Huhn; Bärbel Matthey; Roland Schnell; Samir Tawadros; Timo Schinköthe; Johann Lorenzen; Volker Diehl; Andreas Engert
Recombinant anti-CD25 immunotoxin RFT5(SCFV)-ETA' demonstrates successful elimination of disseminated human Hodgkin lymphoma in SCID mice.
International journal of cancer. Journal international du cancer 2000;86(5):718-24.
2000: Hans Tesch; Andreas Engert; Oliver Manzke; Volker Diehl; Heribert Bohlen
Treatment of patients with malignant lymphomas with monoclonal antibodies.
Bone marrow transplantation 2000;25 Suppl 2():S50-3.
2000: Andreas Müller; Caspar Franzen; P Klussmann; Mathias Wagner; Volker Diehl; Gerd Fätkenheuer; Bernd Salzberger; Dharam V Ablashi; Gerhard R F Krueger
Human herpesvirus type 8 in HIV-infected patients with interstitial pneumonitis.
The Journal of infection 2000;40(3):242-7.
2000: Jeremy Franklin; Ursula Paulus; D Lieberz; Kai Breuer; Hans Tesch; Volker Diehl
Is the international prognostic score for advanced stage Hodgkin's disease applicable to early stage patients? German Hodgkin Lymphoma Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(5):617-23.
2000: Daniel Re; E Benenson; Jürgen Wolf; Volker Diehl; Andrea Staratschek-Jox
Lack of BCL10 mutations in Hodgkin's disease-derived cell lines.
British journal of haematology 2000;109(2):420-2.
2000: L Mantovani; G Lentini; B Hentschel; PD Wickramanayake; Markus Loeffler; Volker Diehl; Hans Tesch
Treatment of anaemia in myelodysplastic syndromes with prolonged administration of recombinant human granulocyte colony-stimulating factor and erythropoietin.
British journal of haematology 2000;109(2):367-75.
2000: S Mücke; Andreas Draube; Axel Polack; M Pawlita; Nadia Massoudi; Andrea Staratschek-Jox; Heribert Bohlen; Georg W Bornkamm; Volker Diehl; Jürgen Wolf
Suppression of the tumorigenic growth of Burkitt's lymphoma cells in immunodeficient mice by cytokine gene transfer using EBV-derived episomal expression vectors.
International journal of cancer. Journal international du cancer 2000;86(3):301-6.
2000: R Walshe; D Waldschmidt; Volker Diehl
[True medicine? Economic analysis and perspectives for medical service].
Der Unfallchirurg 2000;103(4):334-40.
2000: T Pfitzner; Andreas Engert; H Wittor; Timo Schinköthe; F Oberhäuser; Holger Schulz; Volker Diehl; Stefan Barth
A real-time PCR assay for the quantification of residual malignant cells in B cell chronic lymphatic leukemia.
Leukemia 2000;14(4):754-66.
2000: HH Schäfer; Kai Hübel; Heribert Bohlen; Georg Mansmann; K Hegener; B Richarz; F Oberhäuser; Gernot Wassmer; Arnulf H Hölscher; H Pichlmaier; Volker Diehl; Andreas Engert
Perioperative treatment with filgrastim stimulates granulocyte function and reduces infectious complications after esophagectomy.
Annals of hematology 2000;79(3):143-51.
2000: Heribert Bohlen; M Kessler; Michael Sextro; Volker Diehl; Hans Tesch
Poor clinical outcome of patients with Hodgkin's disease and elevated interleukin-10 serum levels. Clinical significance of interleukin-10 serum levels for Hodgkin's disease.
Annals of hematology 2000;79(3):110-3.
2000: S Titzer; O Christensen; Oliver Manzke; Hans Tesch; Jürgen Wolf; Bertold Emmerich; C Carsten; Volker Diehl; Heribert Bohlen
Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects.
British journal of haematology 2000;108(4):805-16.
2000: Andreas Josting; M Reiser; PD Wickramanayake; Ulrich Rueffer; Andreas Draube; Dietmar Söhngen; Hans Tesch; Jürgen Wolf; Volker Diehl; Andreas Engert
Dexa-BEAM: an effective regimen for cytoreduction prior to high-dose chemotherapy with autologous stem cell support for patients with relapsed/refractory mantle-cell lymphoma.
Leukemia & lymphoma 2000;37(1-2):185-7.
2000: Andreas Josting; M Reiser; PD Wickramanayake; Ulrich Rueffer; Andreas Draube; Dietmar Söhngen; Hans Tesch; Jürgen Wolf; Volker Diehl; Andreas Engert
Dexamethasone, carmustine, etoposide, cytarabine, and melphalan (dexa-BEAM) followed by high-dose chemotherapy and stem cell rescue--a highly effective regimen for patients with refractory or relapsed indolent lymphoma.
Leukemia & lymphoma 2000;37(1-2):115-23.
2000: Jens M Chemnitz; Armin Schulz; Aida Salameh; Christof Scheid; R Müller; Andreas Draube; Volker Diehl; Dietmar Söhngen
[Thrombotic thrombocytopenic purpura (Moschkowitz-syndrome) caused by ticlopidine].
Medizinische Klinik (Munich, Germany : 1983) 2000;95(2):96-100.
2000: Reinhard von Wasielewski; S Seth; Jeremy Franklin; Robert Fischer; Klaus Hübner; Martin-Leo Hansmann; Volker Diehl; Axel Georgii
Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors.
Blood 2000;95(4):1207-13.
2000: Daniel Re; Achim Schwenk; P Hegener; SU Bamborschke; Volker Diehl; Hans Tesch
Guillain-Barré syndrome in a patient with non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(2):217-20.
2000: D Lieberz; Michael Sextro; Ursula Paulus; Jeremy Franklin; Hans Tesch; Volker Diehl
How to restrict liver biopsy to high-risk patients in early-stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group.
Annals of hematology 2000;79(2):73-8.
2000: Achim Schwenk; S Schlottmann; Gisela Kremer; Volker Diehl; Bernd Salzberger; Leigh Ward
Fever and sepsis during neutropenia are associated with expansion of extracellular and loss of intracellular water.
Clinical nutrition (Edinburgh, Scotland) 2000;19(1):35-41.
2000: Berit Jungnickel; Andrea Staratschek-Jox; Andreas Bräuninger; Tilmann Spieker; Jürgen Wolf; Volker Diehl; Martin-Leo Hansmann; Klaus Rajewsky; Ralf Küppers
Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma.
The Journal of experimental medicine 2000;191(2):395-402.
2000: Beate Pfistner; Ursula Paulus; Jan-Peter Glossmann; R Walshe; Hans Tesch; Volker Diehl
Can factors influencing in-patient treatment in Hodgkin's disease be identified?--Retrospective analysis of HD6 patients of the GHSG.
Studies in health technology and informatics 2000;77():399-403.
2000: Oliver A Cornely; Bernd Salzberger; Ullrich Bethe; Harald Seifert; Gerd Fätkenheuer; Volker Diehl; Martin Schrappe
Ceftriaxone and cefotaxime are equally effective in the treatment of neutropenic fever.
Antibiotics and chemotherapy 2000;50():37-46.
2000: Hans Michael Kvasnicka; Hans Michael Kvasnicka; Annette Schmitt-Graeff; Thomas K Zirbes; F Birnbaum; C Kressmann; M Melguizo-Grahmann; H Frackenpohl; C Sprungmann; Lutz-Dietrich Leder; Volker Diehl; Rudolph Zankovich; Hans-Eckart Schaefer; Norbert Niederle; R Fischer
Bone marrow features and clinical findings in chronic myeloid leukemia--a comparative, multicenter, immunohistological and morphometric study on 614 patients.
Leukemia & lymphoma 2000;36(3-4):295-308.
2000: Andreas Müller; T Trammer; G Chioralia; Hanns M Seitz; Volker Diehl; Caspar Franzen
Ribosomal RNA of Nosema algerae and phylogenetic relationship to other microsporidia.
Parasitology research 2000;86(1):18-23.
2000: Daniel Re; A Hofmann; Jürgen Wolf; Volker Diehl; Andrea Staratschek-Jox
Cultivated H-RS cells are resistant to CD95L-mediated apoptosis despite expression of wild-type CD95.
Experimental hematology 2000;28(1):31-5.
2000: Hans Michael Kvasnicka; Hans Michael Kvasnicka; Annette Schmitt-Graeff; M Spohr; Volker Diehl; Rudolph Zankovich; Norbert Niederle; Lutz-Dietrich Leder
Effects of interferon and hydroxyurea on bone marrow fibrosis in chronic myelogenous leukaemia: a comparative retrospective multicentre histological and clinical study.
British journal of haematology 2000;108(1):64-71.
2000: Roland Schnell; Ellen S Vitetta; John Schindler; Peter Borchmann; Stefan Barth; Victor Ghetie; K Hell; S Drillich; Volker Diehl; Andreas Engert
Treatment of refractory Hodgkin's lymphoma patients with an anti-CD25 ricin A-chain immunotoxin.
Leukemia 2000;14(1):129-35.
2000: Andreas Josting; M Reiser; Ulrich Rueffer; B Salzberger; Volker Diehl; Andreas Engert
Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(2):332-9.
2000: Andrea Staratschek-Jox; S Kotkowski; Gazanfer Belge; T Rüdiger; Jörn Bullerdiek; Volker Diehl; Jürgen Wolf
Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells : no evidence for the persistence of integrated viral fragments inLatent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease.
The American journal of pathology 2000;156(1):209-16.
1999: Bernd Salzberger; Jürgen Rockstroh; Ulrike Wieland; Caspar Franzen; Achim Schwenk; Alexander Jütte; P Hegener; Oliver A Cornely; C Mörchen; T Gaensicke; Volker Diehl; Gerd Fätkenheuer
Clinical efficacy of protease inhibitor based antiretroviral combination therapy--a prospective cohort study.
European journal of medical research 1999;4(11):449-55.
1999: Ulrich Rueffer; Markus Sieber; Andreas Josting; Kai Breuer; FJ Grotenhermen; Henning Bredenfeld; Hans Tesch; Hiltrud Nisters-Backes; Andreas Engert; Volker Diehl
Prognostic factors for subdiaphragmatic involvement in clinical stage I-II supradiaphragmatic Hodgkin's disease: a retrospective analysis of the GHSG.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(11):1343-8.
1999: Andreas Hombach; Claudia Heuser; R Sircar; T Tillmann; Volker Diehl; C Pohl; Hinrich Abken
Characterization of a chimeric T-cell receptor with specificity for the Hodgkin's lymphoma-associated CD30 antigen.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1999;22(6):473-80.
1999: Hans Michael Kvasnicka; Hans Michael Kvasnicka; B Boeltken; Rudolph Zankovich; Volker Diehl; R Fischer
Initial (prefibrotic) stages of idiopathic (primary) myelofibrosis (IMF) - a clinicopathological study.
Leukemia 1999;13(11):1741-8.
1999: Achim Schwenk; A Beisenherz; Gisela Kremer; Volker Diehl; Bernd Salzberger; Gerd Fätkenheuer
Bioelectrical impedance analysis in HIV-infected patients treated with triple antiretroviral treatment.
The American journal of clinical nutrition 1999;70(5):867-73.
1999: D Schiefer; Claudia Gottstein; Volker Diehl; Andreas Engert
[Anti-angiogenesis: a new approach to tumor therapy?].
Medizinische Klinik (Munich, Germany : 1983) 1999;94(10):570-9.
1999: U Winkler; Markus Jensen; Oliver Manzke; Holger Schulz; Volker Diehl; Andreas Engert
Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody (rituximab, IDEC-C2B8).
Blood 1999;94(7):2217-24.
1999: Alexander Jütte; Achim Schwenk; Caspar Franzen; Katja Römer; Frank Diet; Volker Diehl; Gerd Fätkenheuer; Bernd Salzberger
Increasing morbidity from myocardial infarction during HIV protease inhibitor treatment?
AIDS (London, England) 1999;13(13):1796-7.
1999: H T Steinmetz; A Schulz; Peter Staib; Christof Scheid; A Glasmacher; A Neufang; Jeremy Franklin; Hans Tesch; Volker Diehl; P Dias Wickramanayake
Phase-II trial of idarubicin, fludarabine, cytosine arabinoside, and filgrastim (Ida-FLAG) for treatment of refractory, relapsed, and secondary AML.
Annals of hematology 1999;78(9):418-25.
1999: Claudia Wickenhauser; Peter Borchmann; Volker Diehl; Karin Scharffetter-Kochanek
Development of IgG lambda multiple myeloma in a patient with cutaneous CD30+ anaplastic T-cell lymphoma.
Leukemia & lymphoma 1999;35(1-2):201-6.
1999: Jens M Chemnitz; S Wolter; M H Bohrer; G Brochhagen; W F de Lacroix; Dietmar Söhngen; Volker Diehl; J Wolf
[Massive chronic diarrhea. 56-year-old patient with sarcoidosis and high grade pleomorphic T-cell non-Hodgkin lymphoma].
Der Internist 1999;40(9):969-73.
1999: Oliver Manzke; K J Fitzgerald; Philipp Holliger; J Klock; M Span; Bernd K Fleischmann; Jürgen Hescheler; L Qinghua; K S Johnson; Volker Diehl; H R Hoogenboom; Heribert Bohlen
CD3X anti-nitrophenyl bispecific diabodies: universal immunotherapeutic tools for retargeting T cells to tumors.
International journal of cancer. Journal international du cancer 1999;82(5):700-8.
1999: Gerd Fätkenheuer; Richard Hoetelmans; N Hunn; Achim Schwenk; Caspar Franzen; M Reiser; Alexander Jütte; Jürgen Rockstroh; Volker Diehl; Bernd Salzberger
Salvage therapy with regimens containing ritonavir and saquinavir in extensively pretreated HIV-infected patients.
AIDS (London, England) 1999;13(12):1485-9.
1999: Andreas Engert; Andreas Josting; M Reiser; Dietmar Söhngen; Volker Diehl
[Role of high-dose chemotherapy in hematology and internal medicine/ oncology].
Medizinische Klinik (Munich, Germany : 1983) 1999;94(8):431-42.
1999: Martin Kornacker; A Jox; Martina Vockerodt; Hans Tesch; Heribert Bohlen; Volker Diehl; Jürgen Wolf
Detection of a Hodgkin/Reed-Sternberg cell specific immunoglobulin gene rearrangement in the serum DNA of a patient with Hodgkin's disease.
British journal of haematology 1999;106(2):528-31.
1999: Stefan Barth; Bärbel Matthey; Michael Huhn; Volker Diehl; Andreas Engert
CD30L-ETA': a new recombinant immunotoxin based on the CD30 ligand for possible use against human lymphoma.
Cytokines, cellular & molecular therapy 1999;5(2):69-78.
1999: A Jox; M Sieber; Jürgen Wolf; Volker Diehl
Hodgkin's disease - new treatment strategies toward the cure of patients.
Cancer treatment reviews 1999;25(3):169-76.
1999: M Reiser; Andreas Josting; Andreas Draube; MY Mapara; Christof Scheid; Jens M Chemnitz; Hans Tesch; J Wolf; Volker Diehl; Dietmar Söhngen; Andreas Engert
Successful peripheral blood stem cell mobilization with etoposide (VP-16) in patients with relapsed or resistant lymphoma who failed cyclophosphamide mobilization.
Bone marrow transplantation 1999;23(12):1223-8.
1999: Christof Scheid; Andreas Draube; M Reiser; A Schulz; Jens M Chemnitz; S Nelles; M Fuchs; S Winter; PD Wickramanayake; Volker Diehl; Dietmar Söhngen
Using at least 5x10(6)/kg CD34+ cells for autologous stem cell transplantation significantly reduces febrile complications and use of antibiotics after transplantation.
Bone marrow transplantation 1999;23(11):1177-81.
1999: Achim Schwenk; Gisela Kremer; Oliver A Cornely; Volker Diehl; Gerd Fätkenheuer; Bernd Salzberger
Body weight changes with protease inhibitor treatment in undernourished HIV-infected patients.
Nutrition (Burbank, Los Angeles County, Calif.) 1999;15(6):453-7.
1999: Alexander Klimka; Stefan Barth; Bärbel Matthey; Rob C Roovers; Hilmar Lemke; Hinrich Hansen; Jan-Willem Arends; Volker Diehl; Hennie Hoogenboom; Andreas Engert
An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETA') is a potent immunotoxin against a Hodgkin-derived cell line.
British journal of cancer 1999;80(8):1214-22.
1999: A Jox; Thomas Zander; Ralf Küppers; Johannes Irsch; H Kanzler; Martin Kornacker; Heribert Bohlen; Volker Diehl; Jürgen Wolf
Somatic mutations within the untranslated regions of rearranged Ig genes in a case of classical Hodgkin's disease as a potential cause for the absence of Ig in the lymphoma cells.
Blood 1999;93(11):3964-72.
1999: richard greil; Bernhard Holzner; Georg Kemmler; Martin Kopp; A Buchowski; Wilhelm Oberaigner; E Fritsch; S Dirnhofer; Ulrich Rueffer; Volker Diehl; Barbara Sperner-Unterweger
Retrospective assessment of quality of life and treatment outcome in patients with Hodgkin's disease from 1969 to 1994.
European journal of cancer (Oxford, England : 1990) 1999;35(5):698-706.
1999: Frank Diet; Pia Hartmann; A Lang; Gerd Fätkenheuer; Volker Diehl; Erland Erdmann
[Meningococcal sepsis in 3 young men].
Deutsche medizinische Wochenschrift (1946) 1999;124(14):424-8.
1999: Andreas Engert; K Höffken; M Freund; Volker Diehl
[Hematology and internal medicine oncology].
Der Internist 1999;40(4):356-68.
1999: M Reiser; Andreas Josting; P Dias Wickramanayake; Andreas Draube; Christof Scheid; Hans Tesch; Jürgen Wolf; Volker Diehl; Andreas Engert
Dexa-BEAM is not effective in patients with relapsed or resistant aggressive high-grade non-Hodgkin's lymphoma.
Leukemia & lymphoma 1999;33(3-4):305-12.
1999: Hans Michael Kvasnicka; Hans Michael Kvasnicka; Volker Diehl; R Fischer; J Michiels
Clinicopathological diagnosis and differential criteria of thrombocythemias in various myeloproliferative disorders by histopathology, histochemistry and immunostaining from bone marrow biopsies.
Leukemia & lymphoma 1999;33(3-4):207-18.
1999: Bärbel Matthey; Andreas Engert; Alexander Klimka; Volker Diehl; Stefan Barth
A new series of pET-derived vectors for high efficiency expression of Pseudomonas exotoxin-based fusion proteins.
Gene 1999;229(1-2):145-53.
1999: Volker Diehl; Michael Sextro; Jeremy Franklin; Martin-Leo Hansmann; N Harris; E Jaffe; S Poppema; M Harris; K Franssila; J van Krieken; Teresa Marafioti; Ioannis Anagnostopoulos; Harald Stein
Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):776-83.
1999: Andreas Müller; K Stellermann; Pia Hartmann; Martin Schrappe; Gerd Fätkenheuer; Bernd Salzberger; Volker Diehl; Caspar Franzen
A powerful DNA extraction method and PCR for detection of microsporidia in clinical stool specimens.
Clinical and diagnostic laboratory immunology 1999;6(2):243-6.
1999: Oliver Manzke; Frank Berthold; K Huebel; Hans Tesch; Volker Diehl; Heribert Bohlen
CD3xCD19 bispecific antibodies and CD28 bivalent antibodies enhance T-cell reactivity against autologous leukemic cells in pediatric B-ALL bone marrow.
International journal of cancer. Journal international du cancer 1999;80(5):715-22.
1999: Q H Liu; Heribert Bohlen; S Titzer; O Christensen; Volker Diehl; Jürgen Hescheler; B K Fleischmann
Expression and a role of functionally coupled P2Y receptors in human dendritic cells.
FEBS letters 1999;445(2-3):402-8.
1999: M Reiser; B Salzberger; A Stiepel; Richard Hoetelmans; Volker Diehl; G Fätkenheuer
Virological efficacy and plasma drug concentrations of nelfinavir plus saquinavir as salvage therapy in HIV-infected patients refractory to standard triple therapy.
European journal of medical research 1999;4(2):54-8.
1999: P A Horn; Hans Tesch; Peter Staib; D Kube; Volker Diehl; Dimitris Voliotis
Expression of AC133, a novel hematopoietic precursor antigen, on acute myeloid leukemia cells.
Blood 1999;93(4):1435-7.
1999: Andreas Hombach; D Koch; R Sircar; Claudia Heuser; Volker Diehl; Wolfgang Kruis; C Pohl; Hinrich Abken
A chimeric receptor that selectively targets membrane-bound carcinoembryonic antigen (mCEA) in the presence of soluble CEA.
Gene therapy 1999;6(2):300-4.
1999: Kai Hübel; K Hegener; Roland Schnell; Georg Mansmann; F Oberhäuser; Peter Staib; Volker Diehl; Andreas Engert
Suppressed neutrophil function as a risk factor for severe infection after cytotoxic chemotherapy in patients with acute nonlymphocytic leukemia.
Annals of hematology 1999;78(2):73-7.
1999: Hans Michael Kvasnicka; Hans Michael Kvasnicka; C Regn; Rudolph Zankovich; Volker Diehl; R Fischer
Prognostic impact of apoptosis and proliferation in idiopathic (primary) myelofibrosis.
Annals of hematology 1999;78(2):65-72.
1999: Daniel Re; SU Bamborschke; W Feiden; Rudolph Schröder; Ralph Lehrke; Volker Diehl; Hans Tesch
Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation and alpha-interferon immunotherapy.
Bone marrow transplantation 1999;23(3):295-8.
1999: Martin Hafner; Martina Vockerodt; O Weber; K Hell; Jürgen Wolf; B Haier; Friedrich A Grässer; N Müller-Lantzsch; E Kieff; Volker Diehl; Hans Tesch
Expression of epstein-barr virus nuclear antigen 1 is associated with enhanced expression of CD25 in the Hodgkin cell line L428.
Journal of virology 1999;73(2):1630-6.
1999: Markus Sieber; U Rüffer; Andreas Josting; Volker Diehl; A Jostin
Treatment of Hodgkin's disease: current strategies of the German Hodgkin's Lymphoma Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10 Suppl 6():23-9.
1999: Peter Staib; Bernd Lathan; Timo Schinköthe; S Wiedenmann; B Pantke; T Dimski; Dimitris Voliotis; Volker Diehl
Prognosis in adult AML is precisely predicted by the DISC-assay using the chemosensitivity-index Ci.
Advances in experimental medicine and biology 1999;457():437-44.
1999: Daniel Re; Marcel Reiser; SU Bamborschke; Rudolph Schröder; Ralph Lehrke; Hans Tesch; Bernd Salzberger; Volker Diehl; Gerd Fätkenheuer
Two cases of toxoplasmic encephalitis in patients with acute T-cell leukaemia and lymphoma.
The Journal of infection 1999;38(1):26-9.
1998: Hans Tesch; Volker Diehl; Bernd Lathan; Dirk Hasenclever; Markus Sieber; U Rüffer; Andreas Engert; Jeremy Franklin; Michael Pfreundschuh; K P Schalk; G Schwieder; G Wulf; Gottfried Dölken; P Worst; Peter Koch; Norbert Schmitz; U Bruntsch; C Tirier; U Müller; Markus Loeffler
Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy: a study of the German Hodgkin's Lymphoma Study Group.
Blood 1998;92(12):4560-7.
1998: Dietmar Söhngen; S Wienen; Mario Siebler; C Boogen; Christof Scheid; A Schulz; Guido Kobbe; Volker Diehl; Axel Heyll
Analysis of rhG-CSF-effects on platelets by in vitro bleeding test and transcranial Doppler ultrasound examination.
Bone marrow transplantation 1998;22(11):1087-90.
1998: Volker Diehl; Jeremy Franklin; Dirk Hasenclever; Hans Tesch; Michael Pfreundschuh; Bernd Lathan; Ursula Paulus; Markus Sieber; J U Rueffer; Michael Sextro; Andreas Engert; Jürgen Wolf; R Hermann; L Holmer; U Stappert-Jahn; E Winnerlein-Trump; G Wulf; S Krause; A Glunz; K von Kalle; H Bischoff; C Haedicke; E Duehmke; Axel Georgii; Markus Loeffler
BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(12):3810-21.
1998: Dirk Hasenclever; Volker Diehl
A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease.
The New England journal of medicine 1998;339(21):1506-14.
1998: P Hegener; Peter Troke; Gerd Fätkenheuer; Volker Diehl; M Ruhnke
Treatment of fluconazole-resistant candidiasis with voriconazole in patients with AIDS.
AIDS (London, England) 1998;12(16):2227-8.
1998: Andreas Hombach; C Pohl; Claudia Heuser; R Sircar; D Koch; Volker Diehl; Hinrich Abken
Generation of the single chain antibody fragment conserves the idiotypic profile of the anti-CD30 monoclonal antibody HRS3.
Scandinavian journal of immunology 1998;48(5):497-501.
1998: A Jox; E Taquia; Martina Vockerodt; Andreas Draube; M Pawlita; Peter Möller; Jörn Bullerdiek; Volker Diehl; Jürgen Wolf
Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
Cancer research 1998;58(21):4930-9.
1998: Martina Vockerodt; M Soares; H Kanzler; Ralf Küppers; Martin Hafner; Martin-Leo Hansmann; Volker Diehl; Hans Tesch
Detection of clonal Hodgkin and Reed-Sternberg cells with identical somatically mutated and rearranged VH genes in different biopsies in relapsed Hodgkin's disease.
Blood 1998;92(8):2899-907.
1998: Bertrand Coiffier; C Haioun; N Ketterer; Andreas Engert; Hervé Tilly; D Ma; P Johnson; Andrew Lister; M Feuring-Buske; John A Radford; R Capdeville; Volker Diehl; F Reyes
Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study.
Blood 1998;92(6):1927-32.
1998: Andreas Hombach; C Pohl; Claudia Heuser; R Sircar; Volker Diehl; Hinrich Abken
Isolation of single chain antibody fragments with specificity for cell surface antigens by phage display utilizing internal image anti-idiotypic antibodies.
Journal of immunological methods 1998;218(1-2):53-61.
1998: R Walshe; Volker Diehl
[Economic evaluation within the scope of clinical studies].
Der Internist 1998;39(9):943-54.
1998: Gerd Fätkenheuer; B Salzberger; C Franzen; Volker Diehl
[Clinical studies on the use of protease inhibitors in HIV infection. Answers and questions].
Der Internist 1998;39(9):927-34.
1998: Volker Diehl; J Wolf; R Walshe; Hans Tesch; Markus Loeffler
[Therapy of Hodgkin's disease. Optimization over 4 study generations].
Der Internist 1998;39(9):917-26.
1998: Johannes Irsch; S Nitsch; Martin-Leo Hansmann; Klaus Rajewsky; Hans Tesch; Volker Diehl; A Jox; Ralf Küppers; Andreas Radbruch
Isolation of viable Hodgkin and Reed-Sternberg cells from Hodgkin disease tissues.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(17):10117-22.
1998: Roland Schnell; Ellen S Vitetta; John Schindler; Stefan Barth; U Winkler; Peter Borchmann; M L Hansmann; Volker Diehl; Victor Ghetie; Andreas Engert
Clinical trials with an anti-CD25 ricin A-chain experimental and immunotoxin (RFT5-SMPT-dgA) in Hodgkin's lymphoma.
Leukemia & lymphoma 1998;30(5-6):525-37.
1998: Andreas Hombach; R Sircar; Claudia Heuser; T Tillmann; Volker Diehl; Wolfgang Kruis; C Pohl; Hinrich Abken
Chimeric anti-TAG72 receptors with immunoglobulin constant Fc domains and gamma or zeta signalling chains.
International journal of molecular medicine 1998;2(1):99-103.
1998: Markus Jensen; U Winkler; Oliver Manzke; Volker Diehl; Andreas Engert
Rapid tumor lysis in a patient with B-cell chronic lymphocytic leukemia and lymphocytosis treated with an anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab).
Annals of hematology 1998;77(1-2):89-91.
1998: Gerd Fätkenheuer; Bernd Salzberger; Volker Diehl
[Disseminated infection with Mycobacterium avium complex (MAC) in HIV infection].
Medizinische Klinik (Munich, Germany : 1983) 1998;93(6):360-4.
1998: P Hegener; E Horst; Pia Hartmann; Caspar Franzen; Volker Diehl; Bernd Salzberger; Gerd Fätkenheuer
Asymptomatic pneumatosis intestinalis and free abdominal air in a patient with AIDS.
European journal of medical research 1998;3(5):265-7.
1998: M Kochanek; P Hartmann; G Dölken; B Salzberger; Volker Diehl; Gerd Fätkenheuer
Intracerebellar tuberculoma in a patient with AIDS. A case report.
Zentralblatt für Bakteriologie : international journal of medical microbiology 1998;287(4):427-32.
1998: R Walshe; Andreas Engert; Volker Diehl
[Current developments in hematology and internal medicine oncology].
Der Internist 1998;39(4):346-54.
1998: Andreas Müller; Gerd Fätkenheuer; Bernd Salzberger; Martin Schrappe; Volker Diehl; Caspar Franzen
[Strongyloides stercoralis infection in a patient with AIDS and non-Hodgkin lymphoma].
Deutsche medizinische Wochenschrift (1946) 1998;123(13):381-5.
1998: Andreas Hombach; Claudia Heuser; R Sircar; T Tillmann; Volker Diehl; C Pohl; Hinrich Abken
An anti-CD30 chimeric receptor that mediates CD3-zeta-independent T-cell activation against Hodgkin's lymphoma cells in the presence of soluble CD30.
Cancer research 1998;58(6):1116-9.
1998: Andreas Josting; I Kàtay; Ulrich Rueffer; S Winter; Hans Tesch; Andreas Engert; Volker Diehl; PD Wickramanayake
Favorable outcome of patients with relapsed or refractory Hodgkin's disease treated with high-dose chemotherapy and stem cell rescue at the time of maximal response to conventional salvage therapy (Dex-BEAM).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(3):289-95.
1998: A Jox; Thomas Zander; Martin Kornacker; H Kanzler; Ralf Küppers; Volker Diehl; Jürgen Wolf
Detection of identical Hodgkin-Reed Sternberg cell specific immunoglobulin gene rearrangements in a patient with Hodgkin's disease of mixed cellularity subtype at primary diagnosis and in relapse two and a half years later.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(3):283-7.
1998: Markus Loeffler; Oana Brosteanu; Dirk Hasenclever; Michael Sextro; D Assouline; Alfred A Bartolucci; Peter A Cassileth; D Crowther; Volker Diehl; Richard I Fisher; R T Hoppe; P Jacobs; J L Pater; S Pavlovsky; E Thompson; Peter H Wiernik
Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):818-29.
1998: Peter Staib; Bernd Lathan; S Knöppel-Schwark; Hans Tesch; Dimitris Voliotis; H T Steinmetz; Martin Schwonzen; PD Wickramanayake; Volker Diehl
Cytosine arabinoside, etoposide and aclarubicin (AVA) for the treatment of acute myeloid leukemia (AML) in elderly patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(2):221-3.
1998: Henning Flechtner; JU Rüffer; Michel Henry-Amar; W A Mellink; Markus Sieber; Christophe Fermé; Houchingue Eghbali; Andreas Josting; Volker Diehl
Quality of life assessment in Hodgkin's disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D'Etude des Lymphomes de L'Adulte and German Hodgkin Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9 Suppl 5():S147-54.
1998: Peter Borchmann; Roland Schnell; Volker Diehl; Andreas Engert
New drugs in the treatment of Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9 Suppl 5():S103-8.
1998: Jürgen Wolf; Hans Tesch; R Parsa-Parsi; Andreas Engert; Volker Diehl
Current clinical trials for the treatment of adult Hodgkin's disease: common strategies and perspectives.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9 Suppl 5():S79-82.
1998: Markus Loeffler; Dirk Hasenclever; Volker Diehl
Model based development of the BEACOPP regimen for advanced stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9 Suppl 5():S73-8.
1998: Volker Diehl; Jeremy Franklin; Dirk Hasenclever; Hans Tesch; Michael Pfreundschuh; Bernd Lathan; Ursula Paulus; Markus Sieber; JU Rüffer; Michael Sextro; Andreas Engert; Jürgen Wolf; R Hermann; L Holmer; U Stappert-Jahn; E Winnerlein-Trump; G Wulf; S Krause; A Glunz; K von Kalle; H Bischoff; C Haedicke; Eckhart Dühmke; Axel Georgii; Markus Loeffler
BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9 Suppl 5():S67-71.
1998: Jeremy Franklin; Hans Tesch; Martin-Leo Hansmann; Volker Diehl
Lymphocyte predominant Hodgkin's disease: pathology and clinical implication.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9 Suppl 5():S39-44.
1998: R Parsa-Parsi; Andreas Engert; Volker Diehl
An overview of the Fourth International Symposium on Hodgkin's Disease. Recent advances in basic and clinical research.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9 Suppl 5():S1-3.
1998: Stefan Barth; Michael Huhn; W Wels; Volker Diehl; Andreas Engert
Construction and in vitro evaluation of RFT5(scFv)-ETA', a new recombinant single-chain immunotoxin with specific cytotoxicity toward CD25+ Hodgkin-derived cell lines.
International journal of molecular medicine 1998;1(1):249-56.
1998: Caspar Franzen; Andreas Müller; Pia Hartmann; P Hegener; Martin Schrappe; Volker Diehl; Gerd Fätkenheuer; Bernd Salzberger
Polymerase chain reaction for diagnosis and species differentiation of microsporidia.
Folia parasitologica 1998;45(2):140-8.
1998: M Reiser; C Bruns; Pia Hartmann; B Salzberger; Volker Diehl; Gerd Fätkenheuer
Raynaud's phenomenon and acral necrosis after chemotherapy for AIDS-related Kaposi's sarcoma.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1998;17(1):58-60.
1998: Hans Michael Kvasnicka; Hans Michael Kvasnicka; Thomas K Zirbes; Uta Flucke; Norbert Niederle; Lutz-Dietrich Leder; Volker Diehl; R Fischer
Impact of clinical and morphological variables in classification and regression tree-based survival (CART) analysis of CML with special emphasis on dynamic features.
European journal of haematology 1998;60(1):35-46.
1997: Kai Hübel; Hans Tesch; B Kröger; Roland Schnell; Peter Borchmann; Volker Diehl; Andreas Engert
A phase I/II study of idarubicin, dexamethasone and interferon-alpha (I-Dexa) in patients with relapsed or refractory multiple myeloma.
Leukemia 1997;11 Suppl 5():S47-51.
1997: Gerd Fätkenheuer; Caspar Franzen; Pia Hartmann; Klaus Wassermann; Martin Schrappe; W Dölken; Volker Diehl; Bernd Salzberger
[Cystic form of Pneumocystis carinii pneumonia].
Deutsche medizinische Wochenschrift (1946) 1997;122(47):1441-6.
1997: A Jox; Jürgen Wolf; Volker Diehl
Hodgkin's disease biology: recent advances.
Hematological oncology 1997;15(4):165-71.
1997: Stefan Barth; U Winkler; Volker Diehl; Andreas Engert
[Immunotoxins. Mechanism of action and applications in malignant diseases].
Der Internist 1997;38(11):1063-9.
1997: Oliver Manzke; S Titzer; Hans Tesch; Volker Diehl; Heribert Bohlen
CD3 x CD19 bispecific antibodies and CD28 costimulation for locoregional treatment of low-malignancy non-Hodgkin's lymphoma.
Cancer immunology, immunotherapy : CII 1997;45(3-4):198-202.
1997: Oliver Manzke; Hans Tesch; Volker Diehl; Heribert Bohlen
Single-step purification of bispecific monoclonal antibodies for immunotherapeutic use by hydrophobic interaction chromatography.
Journal of immunological methods 1997;208(1):65-73.
1997: Reinhard von Wasielewski; M Mengel; Robert Fischer; Martin-Leo Hansmann; Klaus Hübner; Jeremy Franklin; Hans Tesch; Ursula Paulus; Martin Werner; Volker Diehl; Axel Georgii
Classical Hodgkin's disease. Clinical impact of the immunophenotype.
The American journal of pathology 1997;151(4):1123-30.
1997: Andreas Hombach; Claudia Heuser; R Sircar; T Tillmann; Volker Diehl; Wolfgang Kruis; C Pohl; Hinrich Abken
T cell targeting of TAG72+ tumor cells by a chimeric receptor with antibody-like specificity for a carbohydrate epitope.
Gastroenterology 1997;113(4):1163-70.
1997: Caspar Franzen; M Altfeld; P Hegener; Pia Hartmann; Gabriele Arendt; H Jablonowski; Jürgen Rockstroh; Volker Diehl; Bernd Salzberger; Gerd Fätkenheuer
Limited value of PCR for detection of Toxoplasma gondii in blood from human immunodeficiency virus-infected patients.
Journal of clinical microbiology 1997;35(10):2639-41.
1997: Roland Schnell; Stefan Barth; Volker Diehl; Andreas Engert
Non-Hodgkin's Lymphoma: A Review of Immunotherapeutic Approaches to Treatment.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 1997;8(3):216-34.
1997: Andreas Hombach; T Tillmann; Markus Jensen; Claudia Heuser; R Sircar; Volker Diehl; Wolfgang Kruis; C Pohl
Specific activation of resting T cells against CA19-9+ tumor cells by an anti-CD3/CA19-9 bispecific antibody in combination with a costimulatory anti-CD28 antibody.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1997;20(5):325-33.
1997: Hans Michael Kvasnicka; Hans Michael Kvasnicka; C Werden; Rudolph Zankovich; Volker Diehl; R Fischer
Prognostic factors in idiopathic (primary) osteomyelofibrosis.
Cancer 1997;80(4):708-19.
1997: A Jox; Thomas Zander; Volker Diehl; Jürgen Wolf
Clonal relapse in Hodgkin's disease.
The New England journal of medicine 1997;337(7):499.
1997: Gerd Fätkenheuer; G Arnold; H M Steffen; Caspar Franzen; M Schrappe; Volker Diehl; Bernd Salzberger
Invasive amoebiasis in two patients with AIDS and cytomegalovirus colitis.
Journal of clinical microbiology 1997;35(8):2168-9.
1997: Hans Michael Kvasnicka; Thomas K Zirbes; Johann Lorenzen; Hans Michael Kvasnicka; S Scholz; A Erdmann; Uta Flucke; Volker Diehl; R Fischer
Hematopoietic turnover index in reactive and neoplastic bone marrow lesions: quantification by apoptosis and PCNA labeling.
Annals of hematology 1997;75(1-2):33-9.
1997: Marcel Reiser; Gerd Fätkenheuer; Volker Diehl
Paradoxical expansion of intracranial tuberculomas during chemotherapy.
The Journal of infection 1997;35(1):88-90.
1997: Norbert Schmitz; Volker Diehl
Carmustine and the lungs .
Lancet 1997;349(9067):1712-3.
1997: Markus Loeffler; Volker Diehl; Michael Pfreundschuh; Ursula Rühl; Dirk Hasenclever; Hiltrud Nisters-Backes; Markus Sieber; Hans Tesch; Jeremy Franklin; W Geilen; H Bartels; C Cartoni; Gottfried Dölken; J Enzian; R Fuchs; W Gassmann; H Gerhartz; U Hagen-Aukamp; E Hiller; H Hinkelbein; W Hinterberger; Hartmut Kirchner; Peter Koch; B Krüger; EW Schwarze
Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2275-87.
1997: Andreas Hombach; S Mathas; Markus Jensen; T Tillmann; M Menges; Volker Diehl; Wolfgang Kruis; C Pohl
Activation of resting T cells against the CA 72-4 tumor antigen with an anti-CD3/CA 72-4 bispecific antibody in combination with a costimulatory anti-CD28 antibody.
Anticancer research 1997;17(3C):2025-32.
1997: Andreas Hombach; T Tillmann; Markus Jensen; Claudia Heuser; R Sircar; Volker Diehl; Wolfgang Kruis; C Pohl
Specific activation of resting T cells against tumour cells by bispecific antibodies and CD28-mediated costimulation is accompanied by Th1 differentiation and recruitment of MHC-independent cytotoxicity.
Clinical and experimental immunology 1997;108(2):352-7.
1997: Heribert Bohlen; Oliver Manzke; S Titzer; Johann Lorenzen; Martin Hafner; Andreas Engert; Hinrich Abken; Jürgen Wolf; Volker Diehl; Hans Tesch
Prevention of Epstein-Barr virus-induced human B-cell lymphoma in severe combined immunodeficient mice treated with CD3xCD19 bispecific antibodies, CD28 monospecific antibodies, and autologous T cells.
Cancer research 1997;57(9):1704-9.
1997: Hans Michael Kvasnicka; Thomas K Zirbes; Johann Lorenzen; Hans Michael Kvasnicka; S Dresbach; B Manich; Lutz-Dietrich Leder; Norbert Niederle; Volker Diehl; R Fischer
Apoptosis and proliferation (PCNA labelling) in CML--a comparative immunohistological study on bone marrow biopsies following interferon and busulfan therapy.
The Journal of pathology 1997;181(3):316-22.
1997: Reinhard von Wasielewski; Martin Werner; Robert Fischer; Martin-Leo Hansmann; Klaus Hübner; Dirk Hasenclever; Jeremy Franklin; Michael Sextro; Volker Diehl; Axel Georgii
Lymphocyte-predominant Hodgkin's disease. An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group.
The American journal of pathology 1997;150(3):793-803.
1997: C Drees; Martin Grond; Brigitte Szelies; M Dietlein; Bernd Salzberger; Volker Diehl; Wolf-Dieter Heiss
[Polyneuropathies in monoclonal gammopathy of undetermined significance: initial manifestation of a lymphoma].
Medizinische Klinik (Munich, Germany : 1983) 1997;92(2):112-6.
1997: Andreas Engert; Roland Schnell; Stefan Barth; Volker Diehl
[Immunotherapy strategies in lymphoma].
Der Internist 1997;38(2):150-6.
1997: Volker Diehl; Markus Sieber; U Rüffer; Bernd Lathan; Dirk Hasenclever; Michael Pfreundschuh; Markus Loeffler; D Lieberz; Peter Koch; M Adler; Hans Tesch
BEACOPP: an intensified chemotherapy regimen in advanced Hodgkin's disease. The German Hodgkin's Lymphoma Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(2):143-8.
1997: Andreas Engert; Roland Schnell; Frithjof C Küpper; Marcel Reiser; M Engelhard; M Wilhelm; Bernd Lathan; S Baltes-Engler; B Winterhalter; M E Scheulen; B Dederichs; Hans Tesch; B Wörmann; Volker Diehl
A phase-II study with idarubicin, ifosfamide and VP-16 (IIVP-16) in patients with refractory or relapsed aggressive and high grade non-Hodgkin's lymphoma.
Leukemia & lymphoma 1997;24(5-6):513-22.
1997: Hans Michael Kvasnicka; Hans Michael Kvasnicka; R Fischer; Volker Diehl
Clinicopathological impact of the interaction between megakaryocytes and myeloid stroma in chronic myeloproliferative disorders: a concise update.
Leukemia & lymphoma 1997;24(5-6):463-81.
1997: S Mũcke; Axel Polack; M Pawlita; D Zehnpfennig; Nadia Massoudi; Heribert Bohlen; W Doerfler; Georg W Bornkamm; Volker Diehl; Jürgen Wolf
Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells.
Gene therapy 1997;4(2):82-92.
1997: Andreas Engert; Volker Diehl; Roland Schnell; A Radszuhn; M T Hatwig; S Drillich; G Schön; Heribert Bohlen; Hans Tesch; M L Hansmann; Stefan Barth; John Schindler; Victor Ghetie; Jonathan Uhr; Ellen S Vitetta
A phase-I study of an anti-CD25 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin's lymphoma.
Blood 1997;89(2):403-10.
1997: A Jox; C Rohen; Gazanfer Belge; S Bartnitzke; M Pawlita; Volker Diehl; Jörn Bullerdiek; Jürgen Wolf
Integration of Epstein-Barr virus in Burkitt's lymphoma cells leads to a region of enhanced chromosome instability.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8 Suppl 2():131-5.
1997: U Winkler; Stefan Barth; Roland Schnell; Volker Diehl; Andreas Engert
The emerging role of immunotoxins in leukemia and lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8 Suppl 1():139-46.
1996: Heribert Bohlen; K Thielemanns; Hans Tesch; Andreas Engert; H J Wolf; B van Camp; J Urbain; Volker Diehl
Idiotype vaccination strategies against a murine B-cell lymphoma: dendritic cells loaded with idiotype and bispecific idiotype x anti-class II antibodies can protect against tumor growth.
Cytokines and molecular therapy 1996;2(4):231-8.
1996: S Schmitz; H Franke; Markus Loeffler; H E Wichmann; Volker Diehl
Model analysis of the contrasting effects of GM-CSF and G-CSF treatment on peripheral blood neutrophils observed in three patients with childhood-onset cyclic neutropenia.
British journal of haematology 1996;95(4):616-25.
1996: Caspar Franzen; Andreas Müller; Pia Hartmann; M Kochanek; Volker Diehl; Gerd Fätkenheuer
Disseminated Encephalitozoon (Septata) intestinalis infection in a patient with AIDS.
The New England journal of medicine 1996;335(21):1610-1.
1996: Caspar Franzen; Andreas Müller; Bernd Salzberger; Pia Hartmann; Volker Diehl; Gerd Fätkenheuer
Uvitex 2B stain for the diagnosis of Isospora belli infections in patients with the acquired immunodeficiency syndrome.
Archives of pathology & laboratory medicine 1996;120(11):1023-5.
1996: PD Wickramanayake; I Katay; Andreas Josting; Volker Diehl
[Adjuvant systemic therapy of breast carcinoma].
Medizinische Klinik (Munich, Germany : 1983) 1996;91(10):646-53.
1996: Peter Borchmann; Volker Diehl; Andreas Engert
[Chronic lymphatic leukemia. Progress in diagnosis and therapy].
Der Internist 1996;37(10):1022-9.
1996: Alexander Klimka; Stefan Barth; S Drillich; W Wels; J van Snick; J C Renauld; H Tesch; Heribert Bohlen; Volker Diehl; Andreas Engert
A deletion mutant of Pseudomonas exotoxin-A fused to recombinant human interleukin-9 (rhIL-9-ETA') shows specific cytotoxicity against IL-9-receptor-expressing cell lines.
Cytokines and molecular therapy 1996;2(3):139-46.
1996: Roland Schnell; Stefan Barth; Volker Diehl; Andreas Engert
Hodgkin's disease. Future treatment strategies: fact or fiction?
Baillière's clinical haematology 1996;9(3):573-93.
1996: H Tesch; M Sieber; Volker Diehl
Hodgkin's disease. Treatment of intermediate stages.
Baillière's clinical haematology 1996;9(3):543-51.
1996: Eckhart Dühmke; Volker Diehl; Markus Loeffler; R P Mueller; U Ruehl; Normann Willich; A Georgii; S Roth; D Matthaei; S Sehlen; O Brosteanu; Dirk Hasenclever; Ralf Wilkowski; K Becker
Randomized trial with early-stage Hodgkin's disease testing 30 Gy vs. 40 Gy extended field radiotherapy alone.
International journal of radiation oncology, biology, physics 1996;36(2):305-10.
1996: Achim Schwenk; E Höffer-Belitz; B Jung; Gisela Kremer; B Bürger; Bernd Salzberger; Volker Diehl; Martin Schrappe
Resting energy expenditure, weight loss, and altered body composition in HIV infection.
Nutrition (Burbank, Los Angeles County, Calif.) 1996;12(9):595-601.
1996: S C Klein; Martin Hafner; Harry F Abts; Volker Diehl; Hans Tesch
Promotion of IL8, IL10, TNF alpha and TNF beta production by EBV infection.
Leukemia research 1996;20(8):633-6.
1996: A Engert; K Reuss; H Tesch; Volker Diehl
Third International Symposium on Hodgkin's Lymphoma in Köln, Germany.
European journal of cancer (Oxford, England : 1990) 1996;32A(9):1483-5.
1996: Caspar Franzen; Andreas Müller; P Hegener; Pia Hartmann; Bernd Salzberger; B Franzen; Volker Diehl; Gerd Fätkenheuer
Polymerase chain reaction for microsporidian DNA in gastrointestinal biopsy specimens of HIV-infected patients.
AIDS (London, England) 1996;10(8):F23-7.
1996: Hans Michael Kvasnicka; Hans Michael Kvasnicka; C Werden; Rudolph Zankovich; Volker Diehl; R Fischer
Idiopathic primary osteo-myelofibrosis: a clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact.
Leukemia & lymphoma 1996;22(3-4):303-17.
1996: Hans Michael Kvasnicka; Thomas K Zirbes; Hans Michael Kvasnicka; Norbert Niederle; J Dammasch; M Schmidt; R Windecker; Lutz-Dietrich Leder; Volker Diehl; R Fischer
Interferon therapy, but not busulfan restores normal-sized megakaryopoiesis in CML--a comparative histo- and immunomorphometric study.
Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology 1996;11(1):31-42.
1996: Hans Michael Kvasnicka; Johann Lorenzen; Thomas K Zirbes; Hans Michael Kvasnicka; C Schilling; M Schwonzen; Volker Diehl; R Fischer
Apoptosis in acute myeloblastic leukemia: follow-up study on trephine biopsies of the bone marrow.
Leukemia & lymphoma 1996;22(1-2):77-82.
1996: Hans Tesch; Volker Diehl
Hodgkin's disease: from basic science to clinical application.
Leukemia 1996;10 Suppl 2():s74-7.
1996: Roland Schnell; A A Katouzi; C Linnartz; G Schoen; S Drillich; Martin-Leo Hansmann; D Schiefer; Stefan Barth; Uwe Zangemeister-Wittke; Rolf A Stahel; Volker Diehl; Andreas Engert
Potent anti-tumor effects of an anti-CD24 ricin A-chain immunotoxin in vitro and in a disseminated human Burkitt's lymphoma model in SCID mice.
International journal of cancer. Journal international du cancer 1996;66(4):526-31.
1996: Caspar Franzen; Andreas Müller; Volker Diehl; Martin Schrappe
[Microsporidia--biology and clinical relevance].
Medizinische Klinik (Munich, Germany : 1983) 1996;91(5):284-94.
1996: H Kanzler; Martin-Leo Hansmann; U Kapp; Jürgen Wolf; Volker Diehl; Klaus Rajewsky; Ralf Küppers
Molecular single cell analysis demonstrates the derivation of a peripheral blood-derived cell line (L1236) from the Hodgkin/Reed-Sternberg cells of a Hodgkin's lymphoma patient.
Blood 1996;87(8):3429-36.
1996: Jürgen Wolf; U Kapp; Heribert Bohlen; Martin Kornacker; C Schoch; B Stahl; S Mücke; C von Kalle; C Fonatsch; H E Schaefer; Martin-Leo Hansmann; Volker Diehl
Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells.
Blood 1996;87(8):3418-28.
1996: F Hartmann; Michael Pfreundschuh; Volker Diehl
[Prognosis and therapy of Hodgkin's disease].
Medizinische Klinik (Munich, Germany : 1983) 1996;91 Suppl 3():75-9.
1996: U Winkler; Heribert Bohlen; V Schirrmacher; G Schlimok; Dimitris Voliotis; M Brach; N Niederle; Hans Tesch; Volker Diehl; Andreas Engert
[Immunotherapy of hemato-oncologic diseases].
Medizinische Klinik (Munich, Germany : 1983) 1996;91(4):226-33.
1996: C Drees; C Postler; M Schwonzen; Volker Diehl; Angela Gause
[Paraproteins and lymphoma in HIV positive patients].
Medizinische Klinik (Munich, Germany : 1983) 1996;91(4):193-8.
1996: F Westermann; Martin Hafner; B Haier; Heribert Bohlen; Andreas Engert; M Zuehlsdorf; Volker Diehl; Hans Tesch
Interleukin 10 inhibits cytokine production of human AML cells.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(4):397-404.
1996: Caspar Franzen; R Kuppers; A Muller; Bernd Salzberger; G Fatkenheuer; B Vetten; Volker Diehl; Martin Schrappe
Genetic evidence for latent Septata intestinalis infection in human immunodeficiency virus-infected patients with intestinal microsporidiosis.
The Journal of infectious diseases 1996;173(4):1038-40.
1996: Bernd Salzberger; Caspar Franzen; Gerd Fätkenheuer; Oliver A Cornely; Achim Schwenk; H Rasokat; Volker Diehl; Martin Schrappe
CMV-antigenemia in peripheral blood for the diagnosis of CMV disease in HIV-infected patients.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;11(4):365-9.
1996: Stefan Barth; Roland Schnell; Volker Diehl; Andreas Engert
Development of immunotoxins for potential clinical use in Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7 Suppl 4():135-41.
1996: K Reuss; Andreas Engert; H Tesch; Volker Diehl
Current clinical trials in Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7 Suppl 4():109-13.
1996: Dirk Hasenclever; Markus Loeffler; Volker Diehl
Rationale for dose escalation of first line conventional chemotherapy in advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7 Suppl 4():95-8.
1996: Michael Sextro; Volker Diehl; Jeremy Franklin; Martin-Leo Hansmann; Ioannis Anagnostopoulos; Teresa Marafioti; Harald Stein
Lymphocyte predominant Hodgkin's disease--a workshop report. European Task Force on Lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7 Suppl 4():61-5.
1996: J Wolf; Heribert Bohlen; Volker Diehl
Report on the workshop biology of the Third International Symposium on Hodgkin's Lymphoma in Cologne 1995.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7 Suppl 4():45-7.
1995: PD Wickramanayake; Christof Scheid; Andreas Josting; I Katay; A Schulz; Volker Diehl
Use of granulocyte colony-stimulating factor (filgrastim) in the treatment of non-cytotoxic drug-induced agranulocytosis.
European journal of medical research 1995;1(3):153-6.
1995: Caspar Franzen; D A Schwartz; G S Visvesvara; Andreas Müller; Achim Schwenk; Bernd Salzberger; Gerd Fätkenheuer; Pia Hartmann; G Mahrle; Volker Diehl
Immunologically confirmed disseminated, asymptomatic Encephalitozoon cuniculi infection of the gastrointestinal tract in a patient with AIDS.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(6):1480-4.
1995: Volker Diehl; Markus Loeffler; Michael Pfreundschuh; U Ruehl; Dirk Hasenclever; Hiltrud Nisters-Backes; Markus Sieber; K Smith; Hans Tesch; W Geilen
Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advance Hodgkin's disease. German Hodgkins' Study Group (GHSG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(9):901-10.
1995: Caspar Franzen; Andreas Müller; Achim Schwenk; Bernd Salzberger; Gerd Fätkenheuer; G Mahrle; Volker Diehl; Martin Schrappe
Intestinal microsporidiosis with Septata intestinalis in a patient with AIDS--response to albendazole.
The Journal of infection 1995;31(3):237-9.
1995: Caspar Franzen; Andreas Müller; Bernd Salzberger; Gerd Fätkenheuer; S Eidt; G Mahrle; Volker Diehl; Martin Schrappe
Tissue diagnosis of intestinal microsporidiosis using a fluorescent stain with Uvitex 2B.
Journal of clinical pathology 1995;48(11):1009-10.
1995: Andreas Engert; C Gottstein; Heribert Bohlen; U Winkler; G Schön; O Manske; Roland Schnell; Volker Diehl; P Thorpe
Cocktails of ricin A-chain immunotoxins against different antigens on Hodgkin and Sternberg-Reed cells have superior anti-tumor effects against H-RS cells in vitro and solid Hodgkin tumors in mice.
International journal of cancer. Journal international du cancer 1995;63(2):304-9.
1995: Roland Schnell; C Linnartz; A A Katouzi; G Schön; Heribert Bohlen; O Horn-Lohrens; R M Parwaresch; Hans Lange; Volker Diehl; Hilmar Lemke
Development of new ricin A-chain immunotoxins with potent anti-tumor effects against human Hodgkin cells in vitro and disseminated Hodgkin tumors in SCID mice using high-affinity monoclonal antibodies directed against the CD30 antigen.
International journal of cancer. Journal international du cancer 1995;63(2):238-44.
1995: Gerd Fätkenheuer; Volker Diehl; Martin Schrappe
[Clinical aspects and therapy of ubiquitous mycobacterioses].
Der Internist 1995;36(10):987-94.
1995: Jürgen Wolf; A Jox; H Skarbek; T Pukrop; S Bartnitzke; M Pawlita; Volker Diehl; Jörn Bullerdiek
Selective loss of integrated Epstein-Barr virus genomes after long-term cultivation of Burkitt's lymphoma x B-lymphoblastoid cell hybrids due to chromatin instability at the integration site.
Virology 1995;212(1):179-85.
1995: Caspar Franzen; Andreas Müller; P Hegener; Bernd Salzberger; Pia Hartmann; Gerd Fätkenheuer; Volker Diehl; Martin Schrappe
Detection of microsporidia (Enterocytozoon bieneusi) in intestinal biopsy specimens from human immunodeficiency virus-infected patients by PCR.
Journal of clinical microbiology 1995;33(9):2294-6.
1995: Caspar Franzen; Bernd Salzberger; Gerd Fätkenheuer; D Ziegenhagen; Oliver A Cornely; Volker Diehl; Martin Schrappe
Stimulated duodenal/bile juice aspiration for diagnosis of enteric pathogens in HIV-infected patients.
Journal of clinical gastroenterology 1995;21(1):33-7.
1995: D T Nguyen; L W Diamond; M Schwonzen; Heribert Bohlen; Volker Diehl
Chronic lymphocytic leukemia with an interfollicular architecture: avoiding diagnostic confusion with monocytoid B-cell lymphoma.
Leukemia & lymphoma 1995;18(1-2):179-84.
1995: M Gorschlüter; Heribert Bohlen; Dirk Hasenclever; Volker Diehl; Hans Tesch
Serum cytokine levels correlate with clinical parameters in Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(5):477-82.
1995: S Schmitz; H Franke; H E Wichmann; Volker Diehl
The effect of continuous G-CSF application in human cyclic neutropenia: a model analysis.
British journal of haematology 1995;90(1):41-7.
1995: Ralf Küppers; Martin-Leo Hansmann; Volker Diehl; Klaus Rajewsky
Molecular single-cell analysis of Hodgkin and Reed-Sternberg cells.
Molecular medicine today 1995;1(1):26-30.
1995: Hans Tesch; W Doerfler; Andreas Engert; M Hansmann; Andreas Radbruch; K Rajewsky; J Wolf; Volker Diehl
[Immune dysregulation and malignant lymphoma].
Der Internist 1995;36(4):367-71.
1995: Thomas K Zirbes; Andreas Engert; J Thiele; Volker Diehl
[Sarcoidosis and chronic idiopathic thrombocytopenic purpura].
Medizinische Klinik (Munich, Germany : 1983) 1995;90(3):138-40.
1995: Hans Michael Kvasnicka; Hans Michael Kvasnicka; Norbert Niederle; Thomas K Zirbes; M Schmidt; J Dammasch; B R Meuter; Lutz-Dietrich Leder; O Kloke; Volker Diehl
The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML--a comparative morphometric study on sequential trephine biopsies.
Annals of hematology 1995;70(3):121-8.
1995: Jürgen Wolf; Andreas Draube; Heribert Bohlen; A Jox; S Mücke; M Pawlita; P Möller; Volker Diehl
Suppression of Burkitt's lymphoma tumorigenicity in nude mice by co-inoculation of EBV-immortalized lymphoblastoid cells.
International journal of cancer. Journal international du cancer 1995;60(4):527-33.
1995: R Munker; Dirk Hasenclever; O Brosteanu; E Hiller; Volker Diehl
Bone marrow involvement in Hodgkin's disease: an analysis of 135 consecutive cases. German Hodgkin's Lymphoma Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(2):403-9.
1995: S Schmitz; J Wolf; Volker Diehl
[Etiological assessment of lymphadenopathy].
Der Internist 1995;36(2):139-45.
1995: H T Steinmetz; A Herbertz; M Bertram; Volker Diehl
Increase in interleukin-6 serum level preceding fever in granulocytopenia and correlation with death from sepsis.
The Journal of infectious diseases 1995;171(1):225-8.
1995: Dirk Hasenclever; Norbert Schmitz; Volker Diehl
Is there a rationale for high-dose chemotherapy as first line treatment of advanced Hodgkin's disease? German Hodgkin's Lymphoma Study Group (GHSG).
Leukemia & lymphoma 1995;15 Suppl 1():47-9.
1995: Jürgen Wolf; Volker Diehl
Biology and therapy of Hodgkin's disease.
European journal of cancer (Oxford, England : 1990) 1995;31A(5):830-1.
1994: C Gottstein; G Schön; S Tawadros; Martin Hafner; U C Wargalla-Plate; Martin-Leo Hansmann; H H Wacker; F Berthold; Volker Diehl; Andreas Engert
Antidisialoganglioside ricin A-chain immunotoxins show potent antitumor effects in vitro and in a disseminated human neuroblastoma severe combined immunodeficiency mouse model.
Cancer research 1994;54(23):6186-93.
1994: Bernd Salzberger; Martin Schrappe; Volker Diehl
[Antiretroviral therapy in adult HIV-infected patients].
Der Internist 1994;35(12):1095-104.
1994: D Spickermann; Angela Gause; Michael Pfreundschuh; A K Von Kalle; Heribert Bohlen; Volker Diehl
Impaired antibody levels to tetanus toxoid and pneumococcal polysaccharides in acute leukemias.
Leukemia & lymphoma 1994;16(1-2):89-96.
1994: Andreas Engert; Roland Schnell; Bernd Lathan; Volker Diehl
[Limits and value of chemotherapy in elderly patients].
Medizinische Klinik (Munich, Germany : 1983) 1994;89(11):603-10.
1994: B Bürger; Achim Schwenk; H Jünger; G Ollenschläger; D Wessel; Volker Diehl; Martin Schrappe
Oral supplements in HIV-infected patients with chronic wasting. A prospective trial.
Medizinische Klinik (Munich, Germany : 1983) 1994;89(11):579-81, 633.
1994: S H Schmitz; Dimitris Voliotis; J Schimke; Volker Diehl
Continuous 5-fluorouracil and leucovorin as a second-line therapy for advanced gastric carcinoma.
Oncology 1994;51(6):502-6.
1994: Claus Bartels; R Hönig; G Burger; Volker Diehl; R de Vivie
The significance of anticardiolipin antibodies and anti-heart muscle antibodies for the diagnosis of postpericardiotomy syndrome.
European heart journal 1994;15(11):1494-9.
1994: Caspar Franzen; Gerd Fätkenheuer; Bernd Salzberger; Andreas Müller; G Mahrle; Volker Diehl; Martin Schrappe
Intestinal microsporidiosis in patients with acquired immunodeficiency syndrome--report of three more German cases.
Infection 1994;22(6):417-9.
1994: Volker Diehl; Michel Marty
Efficacy and safety of antiemetics.
Cancer treatment reviews 1994;20(4):379-92.
1994: S H Schmitz; S Scheding; Dimitris Voliotis; H Rasokat; Volker Diehl; Martin Schrappe
Side effects of AZT prophylaxis after occupational exposure to HIV-infected blood.
Annals of hematology 1994;69(3):135-8.
1994: W Tacke; Wolfgang Kruis; E Zehnter; D Ziegenhagen; S Velasco; Volker Diehl
[Endosonographic findings in the upper gastrointestinal tract in staging of malignant nodal and extranodal lymphomas].
Zeitschrift für Gastroenterologie 1994;32(8):431-5.
1994: Heribert Bohlen; Oliver Manzke; Andreas Engert; M Hertel; R Hippler-Altenburg; Volker Diehl; Hans Tesch
Differentiation of cytotoxicity using target cells labelled with europium and samarium by electroporation.
Journal of immunological methods 1994;173(1):55-62.
1994: Hans Michael Kvasnicka; Y S Chen; Hans Michael Kvasnicka; Volker Diehl; R Fischer
Evolution of fibro-osteosclerotic bone marrow lesions in primary (idiopathic) osteomyelofibrosis--a histomorphometric study on sequential trephine biopsies.
Leukemia & lymphoma 1994;14(1-2):163-9.
1994: C Renner; W Jung; Ugur Sahin; R Denfeld; C Pohl; L Trümper; F Hartmann; Volker Diehl; R van Lier; Michael Pfreundschuh
Cure of xenografted human tumors by bispecific monoclonal antibodies and human T cells.
Science (New York, N.Y.) 1994;264(5160):833-5.
1994: Andreas Engert; C Gottstein; U Winkler; P Amlot; S Pileri; Volker Diehl; P Thorpe
Experimental treatment of human Hodgkin's disease with ricin A-chain immunotoxins.
Leukemia & lymphoma 1994;13(5-6):441-8.
1994: I Schobert; C Renner; Michael Pfreundschuh; Volker Diehl; C Pohl
Mimicry of the Hodgkin-associated IRAC antigen by an anti-idiotype network: potential use in active immunotherapy of Hodgkin's lymphoma.
Leukemia & lymphoma 1994;13(5-6):429-40.
1994: Volker Diehl; Andreas Engert
[Controversies in therapy of malignant lymphomas].
Der Internist 1994;35(4):313-22.
1994: S Schmitz; Hans Tesch; Heribert Bohlen; Andreas Engert; Volker Diehl
[Chronic fatigue syndrome].
Medizinische Klinik (Munich, Germany : 1983) 1994;89(3):154-9.
1994: U Winkler; C Gottstein; G Schön; U Kapp; Jürgen Wolf; Martin-Leo Hansmann; Heribert Bohlen; P Thorpe; Volker Diehl; Andreas Engert
Successful treatment of disseminated human Hodgkin's disease in SCID mice with deglycosylated ricin A-chain immunotoxins.
Blood 1994;83(2):466-75.
1994: Manfred Jücker; A Günther; G Gradl; C Fonatsch; G Krueger; Volker Diehl; Hans Tesch
The Met/hepatocyte growth factor receptor (HGFR) gene is overexpressed in some cases of human leukemia and lymphoma.
Leukemia research 1994;18(1):7-16.
1994: Lorenz Trümper; W Jung; G Dahl; Volker Diehl; Angela Gause; Michael Pfreundschuh
Interleukin-7, interleukin-8, soluble TNF receptor, and p53 protein levels are elevated in the serum of patients with Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 1():93-6.
1994: Jürgen Wolf; Volker Diehl
Is Hodgkin's disease an infectious disease?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 1():105-11.
1994: C Gottstein; U Winkler; Heribert Bohlen; Volker Diehl; Andreas Engert
Immunotoxins: is there a clinical value?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 1():97-103.
1993: Andreas Hombach; W Jung; C Pohl; C Renner; Ugur Sahin; R Schmits; Jürgen Wolf; U Kapp; Volker Diehl; Michael Pfreundschuh
A CD16/CD30 bispecific monoclonal antibody induces lysis of Hodgkin's cells by unstimulated natural killer cells in vitro and in vivo.
International journal of cancer. Journal international du cancer 1993;55(5):830-6.
1993: Heribert Bohlen; T Hopff; Oliver Manzke; Andreas Engert; Martin Hafner; PD Wickramanayake; Volker Diehl; Hans Tesch
Lysis of malignant B cells from patients with B-chronic lymphocytic leukemia by autologous T cells activated with CD3 x CD19 bispecific antibodies in combination with bivalent CD28 antibodies.
Blood 1993;82(6):1803-12.
1993: Heribert Bohlen; Oliver Manzke; B Patel; G Moldenhauer; B Dörken; V von Fliedner; Volker Diehl; Hans Tesch
Cytolysis of leukemic B-cells by T-cells activated via two bispecific antibodies.
Cancer research 1993;53(18):4310-4.
1993: Achim Schwenk; B Büger; D Wessel; Hartmut Stützer; D Ziegenhagen; Volker Diehl; Martin Schrappe
Clinical risk factors for malnutrition in HIV-1-infected patients.
AIDS (London, England) 1993;7(9):1213-9.
1993: C Renner; Michael Pfreundschuh; Volker Diehl; C Pohl
Active specific immunotherapy of Hodgkin's lymphoma by an anti-idiotype vaccine against the Hodgkin-associated CD30 antigen.
Annals of the New York Academy of Sciences 1993;690():352-4.
1993: C Pohl; R Denfeld; C Renner; W Jung; Heribert Bohlen; Ugur Sahin; Andreas Hombach; R van Lier; M Schwonzen; Volker Diehl
CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphoma.
International journal of cancer. Journal international du cancer 1993;54(5):820-7.
1993: Hans Tesch; A Günther; Harry F Abts; Manfred Jücker; S Klein; Gerhard R F Krueger; Volker Diehl
Expression of interleukin-2R alpha and interleukin-2R beta in Hodgkin's disease.
The American journal of pathology 1993;142(6):1714-20.
1993: Jürgen Wolf; M Pawlita; A Jox; S Kohls; S Bartnitzke; Volker Diehl; Jörn Bullerdiek
Integration of Epstein Barr virus near the breakpoint of a translocation 11;19 in a Burkitt's lymphoma cell line.
Cancer genetics and cytogenetics 1993;67(2):90-4.
1993: Hans Michael Kvasnicka; Hans Michael Kvasnicka; B R Titius; U Parpert; R Nebel; Rudolph Zankovich; D Dienemann; Harald Stein; Volker Diehl; R Fischer
Histological features of prognostic significance in CML--an immunohistochemical and morphometric study (multivariate regression analysis) on trephine biopsies of the bone marrow.
Annals of hematology 1993;66(6):291-302.
1993: C Pohl; C Renner; M Schwonzen; I Schobert; V Liebenberg; W Jung; Jürgen Wolf; Michael Pfreundschuh; Volker Diehl
CD30-specific AB1-AB2-AB3 internal image antibody network: potential use as anti-idiotype vaccine against Hodgkin's lymphoma.
International journal of cancer. Journal international du cancer 1993;54(3):418-25.
1993: Caspar Franzen; Gerd Fätkenheuer; Bernd Salzberger; D Ziegenhagen; H M Seitz; Volker Diehl; Martin Schrappe
[Isospora belli infection in an AIDS patient].
Medizinische Klinik (Munich, Germany : 1983) 1993;88(5):330-2.
1993: H T Steinmetz; L Mantovani; Volker Diehl
[Clinical importance of colony stimulating factors].
Medizinische Klinik (Munich, Germany : 1983) 1993;88(3):146-54.
1993: Volker Diehl
Dose-escalation study for the treatment of Hodgkin's disease. The German Hodgkin Study Group (GHSG).
Annals of hematology 1993;66(3):139-40.
1993: Jürgen Wolf; M Pawlita; B Klevenz; B Frech; U K Freese; N Müller-Lantzsch; Volker Diehl; Harald zur Hausen
Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells.
International journal of cancer. Journal international du cancer 1993;53(4):621-7.
1993: M Schwonzen; C Pohl; T Steinmetz; W Seckler; B Vetten; Hans Michael Kvasnicka; D Wickramanayake; Volker Diehl
Immunophenotyping of low-grade B-cell lymphoma in blood and bone marrow: poor correlation between immunophenotype and cytological/histological classification.
British journal of haematology 1993;83(2):232-9.
1993: Hans Tesch; Harald Stein; Volker Diehl
[Cellular and molecular biology of malignant lymphoma].
Der Internist 1993;34(2):89-96.
1993: Bernd Lathan; Michael Pfreundschuh; Volker Diehl
[Therapeutic strategies of Hodgkin's disease].
Der Internist 1993;34(2):146-54.
1993: Dietrich Peest; R Coldewey; HR Deicher; M Sailer; C Vykoupil; R Leo; Axel Georgii; J Karow; E Hoeppner; Volker Diehl
Prognostic value of clinical, laboratory, and histological characteristics in multiple myeloma: improved definition of risk groups.
European journal of cancer (Oxford, England : 1990) 1993;29A(7):978-83.
1993: B Bürger; G Ollenschläger; Martin Schrappe; A Stute; M Fischer; D Wessel; Achim Schwenk; Volker Diehl
Nutrition behavior of malnourished HIV-infected patients and intensified oral nutritional intervention.
Nutrition (Burbank, Los Angeles County, Calif.) 1993;9(1):43-4.
1993: Peter Volling; Markus Jungehülsing; Manfred Jücker; Hartmut Stützer; Volker Diehl; Hans Tesch
Coamplification of the hst and bcl-1 oncogenes in advanced squamous cell carcinomas of the head and neck.
European journal of cancer (Oxford, England : 1990) 1993;29A(3):383-9.
1992: M Petit; Klaus Wassermann; Mathias Vierbuchen; E Schell-Frederick; R Fischer; A Bolte; Volker Diehl
[Non-puerperal granulomatous mastitis: sarcoidosis or nonspecific inflammatory reaction?].
Medizinische Klinik (Munich, Germany : 1983) 1992;87(12):663-6.
1992: Andreas Engert; C Gottstein; U Winkler; G Schön; P Amlot; P Thorpe; Volker Diehl
[New perspectives in oncology: is selective destruction of tumor cells with immunotoxins in Hodgkin's disease an additional therapeutic alternative?].
Medizinische Klinik (Munich, Germany : 1983) 1992;87(10):503-9.
1992: Martin Schrappe; Klaus Wassermann; D Ziegenhagen; Bernd Salzberger; Gerd Fätkenheuer; Achim Schwenk; A Hiersche; Volker Diehl
[Pneumocystis carinii in oncologic diseases].
Medizinische Klinik (Munich, Germany : 1983) 1992;87 Suppl 1():65-70.
1992: U Kapp; Jürgen Wolf; C von Kalle; S Tawadros; A Röttgen; Andreas Engert; C Fonatsch; Harald Stein; Volker Diehl
Preliminary report: growth of Hodgkin's lymphoma derived cells in immune compromised mice.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3 Suppl 4():21-3.
1992: Hans Tesch; A C Feller; Manfred Jücker; S Klein; H Merz; Volker Diehl
Activation of cytokines in Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3 Suppl 4():13-6.
1992: Volker Diehl; Andreas Engert
An overview of the Second International Symposium on Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3 Suppl 4():1-3.
1992: Andreas Engert; C Pohl; Volker Diehl
Experimental therapy in Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3 Suppl 4():97-100.
1992: L da Costa; Patrice Carde; Jean Lumbroso; Marcel Ricard; Michael Pfreundschuh; Jacques Bosq; L Manil; Volker Diehl; Claude Parmentier
Immunoscintigraphy in Hodgkin's disease and anaplastic large cell lymphomas: results in 18 patients using the iodine radiolabeled monoclonal antibody HRS-3.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3 Suppl 4():53-7.
1992: Angela Gause; W Jung; R Schmits; A Tschiersch; R Scholz; C Pohl; Dirk Hasenclever; Volker Diehl; Michael Pfreundschuh
Soluble CD8, CD25 and CD30 antigens as prognostic markers in patients with untreated Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3 Suppl 4():49-52.
1992: Michael Pfreundschuh; Bernd Lathan; Markus Loeffler; U Rüffer; Dirk Hasenclever; Volker Diehl
The Second International Symposium on Hodgkin's Disease. Workshop III: Recommendations for future clinical trials.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3 Suppl 4():101-4.
1992: K Koch; Hans Tesch; S Eidt; G Krueger; Volker Diehl
Analysis of c-myc, bcl-1 and bcl-2 translocations in human lymphoma by pulsed-field gel electrophoresis.
Leukemia & lymphoma 1992;7(5-6):463-72.
1992: G Ollenschläger; W Thomas; K Konkol; Volker Diehl; Erich Roth
Nutritional behaviour and quality of life during oncological polychemotherapy: results of a prospective study on the efficacy of oral nutrition therapy in patients with acute leukaemia.
European journal of clinical investigation 1992;22(8):546-53.
1992: Damian Franzen; J M Curtius; W Heitz; Hans W Höpp; Volker Diehl; H H Hilger
Cardiac involvement during and after malaria.
The Clinical investigator 1992;70(8):670-3.
1992: Angela Gause; W Jung; S Keymis; I Schobert; R Scholz; R Schmits; Volker Diehl; C Pohl; Dirk Hasenclever; Michael Pfreundschuh
The clinical significance of cytokines and soluble forms of membrane-derived activation antigens in the serum of patients with Hodgkin's disease.
Leukemia & lymphoma 1992;7(5-6):439-47.
1992: Hans Tesch; Manfred Jücker; S Klein; Harry F Abts; A Günther; Gerhard R F Krueger; Volker Diehl
Hodgkin and Reed-Sternberg cells express interleukin 6 and interleukin 6 receptors.
Leukemia & lymphoma 1992;7(4):297-303.
1992: M Schwonzen; C Pohl; T Steinmetz; PD Wickramanayake; Hans Michael Kvasnicka; Volker Diehl
Bone marrow involvement in non-Hodgkin's lymphoma: increased diagnostic sensitivity by combination of immunocytology, cytomorphology and trephine histology.
British journal of haematology 1992;81(3):362-9.
1992: Manfred Jücker; Anton J M Roebroek; Josef Mautner; K Koch; Dirk Eick; Volker Diehl; Wim J M Van De Ven; Hans Tesch
Expression of truncated transcripts of the proto-oncogene c-fps/fes in human lymphoma and lymphoid leukemia cell lines.
Oncogene 1992;7(5):943-52.
1992: Angela Gause; S Keymis; R Scholz; I Schobert; W Jung; Volker Diehl; C Pohl; Michael Pfreundschuh
Increased levels of circulating cytokines in patients with untreated Hodgkin's disease.
Lymphokine and cytokine research 1992;11(2):109-13.
1992: M Schwonzen; R Schmits; Stephan E Baldus; Mathias Vierbuchen; Franz-Georg Hanisch; Michael Pfreundschuh; Volker Diehl; J Bara; G Uhlenbruck
Monoclonal antibody FW6 generated against a mucin-carbohydrate of human amniotic fluid recognises a colonic tumour-associated epitope.
British journal of cancer 1992;65(4):559-65.
1992: C Pohl; C Renner; M Schwonzen; M Sieber; P Lorenz; Michael Pfreundschuh; Volker Diehl
Anti-idiotype vaccine against Hodgkin's lymphoma: induction of B- and T-cell immunity across species barriers against CD30 antigen by murine monoclonal internal image antibodies.
International journal of cancer. Journal international du cancer 1992;50(6):958-67.
1992: C Pohl; I Schobert; A Moter; E M Woll; M Schwonzen; A Hiersche; Volker Diehl
Serum erythropoietin levels in patients with Hodgkin's lymphoma at the time of diagnosis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(2):172-3.
1992: R Hönig; Angela Gause; G Krueger; Dimitris Voliotis; E Zehnter; Volker Diehl
[Midline granuloma in a Korean patient].
Medizinische Klinik (Munich, Germany : 1983) 1992;87(1):16-20.
1992: A Linden; C Gückel; Randolf A Widder; Markus Jungehülsing; Volker Diehl; Harald Schicha
[NMR tomography in plasmacytoma].
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1992;156(1):83-8.
1992: Hans Tesch; M Michels; Manfred Jücker; I Pahl; S Klein; H Bading; K Moelling; Volker Diehl
Heterogeneous expression of c-myb protein in human leukemia detected by simultaneous two color flow cytometric analysis.
Leukemia research 1992;16(3):265-74.
1992: Angela Gause; G Schmitz; A K von Kalle; Bernd Lathan; Volker Diehl; Michael Pfreundschuh
The clinical relevance of IgG subclasses in acute leukemias: low serum IgG as a risk factor for early death due to infection in acute myelogenous leukemia.
Leukemia research 1992;16(2):165-71.
1992: U Kapp; Jürgen Wolf; C von Kalle; Harald Stein; C Fonatsch; E Schell-Frederick; Volker Diehl
Recent efforts to establish an in vivo model as a new experimental tool in the study of Hodgkin's disease.
European journal of cancer (Oxford, England : 1990) 1992;28A(8-9):1408-11.
1992: C von Kalle; Volker Diehl
Hodgkin's disease: analysis of cell line data.
International review of experimental pathology 1992;33():185-203.
1991: Martin Schrappe; C Pohl; Hans Tesch; Volker Diehl
[HIV-associated non-hodgkin lymphoma. Prognosis and therapeutic options].
Medizinische Klinik (Munich, Germany : 1983) 1991;86(12):646-54, 660.
1991: W Tacke; Wolfgang Kruis; E Zehnter; D Ziegenhagen; Volker Diehl
[Endoscopic ultrasonography--possibilities and limitations in the gastrointestinal tract].
Medizinische Klinik (Munich, Germany : 1983) 1991;86(12):639-45.
1991: Angela Gause; R Scholz; S Klein; W Jung; Volker Diehl; H Tesch; Dirk Hasenclever; Michael Pfreundschuh
Increased levels of circulating interleukin-6 in patients with Hodgkin's disease.
Hematological oncology 1991;9(6):307-13.
1991: Andreas Engert; G Martin; P Amlot; J Wijdenes; Volker Diehl; P Thorpe
Immunotoxins constructed with anti-CD25 monoclonal antibodies and deglycosylated ricin A-chain have potent anti-tumour effects against human Hodgkin cells in vitro and solid Hodgkin tumours in mice.
International journal of cancer. Journal international du cancer 1991;49(3):450-6.
1991: Angela Gause; K Verpoort; V Roschansky; A Tschiersch; Dirk Hasenclever; R Schmits; Volker Diehl; O Brosteanu; Michael Pfreundschuh
The clinical significance of serum CD8 antigen levels in adult patients with Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2(8):579-83.
1991: C Pohl; M Pollok; Damian Franzen; Angela Gause; Volker Diehl
[Type II mixed cryoglobulinemia in chronic hepatitis].
Medizinische Klinik (Munich, Germany : 1983) 1991;86(8):410-3.
1991: P D Wickramanayake; J Pallenschat; Volker Diehl
[Chronic myelomonocytic leukemia--myelodysplastic syndrome].
Medizinische Klinik (Munich, Germany : 1983) 1991;86(8):383-6.
1991: F Hartmann; T Gheorghiu; H Leupold; Frank M Baer; Volker Diehl
Serratia infections in patients with neutropenia.
Klinische Wochenschrift 1991;69(11):491-4.
1991: Hans Tesch; Bernd Lathan; Volker Diehl
[Malignant lymphomas in HIV infected patients].
Der Internist 1991;32(8):495-8.
1991: S Achten; A Behn-Krappa; Manfred Jücker; Jörg Sprengel; I Hölker; Birgit Schmitz; Hans Tesch; Volker Diehl; Walter Doerfler
Patterns of DNA methylation in selected human genes in different Hodgkin's lymphoma and leukemia cell lines and in normal human lymphocytes.
Cancer research 1991;51(14):3702-9.
1991: E Schell-Frederick; G Karrenbrock; T Tepass; E Risch; Volker Diehl
Identification and quantification of human peripheral blood lymphocytes and monocytes following migration into nitrocellulose filters.
Journal of immunological methods 1991;139(1):25-30.
1991: E Zehnter; Harald Seifert; M Petit; Georg Plum; G Peters; Volker Diehl
[A protracted course in Cardiobacterium hominis endocarditis].
Deutsche medizinische Wochenschrift (1946) 1991;116(20):768-71.
1991: Hans Tesch; C Fonatsch; Volker Diehl
Rearrangements of immunoglobulin- and BCR-genes in chronic myeloid leukemia.
In vivo (Athens, Greece) 1991;5(3):233-8.
1991: Angela Gause; C Pohl; A Tschiersch; L Da Costa; W Jung; Volker Diehl; Dirk Hasenclever; Michael Pfreundschuh
Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease.
Blood 1991;77(9):1983-8.
1991: C Pohl; M Sieber; Volker Diehl; Michael Pfreundschuh
Idiotype vaccine against Hodgkin's lymphoma: generation and characterization of an anti-idiotypic monoclonal antibody against the Hodgkin-associated (anti-CD 30) monoclonal antibody HRS-3.
Anticancer research 1991;11(3):1115-24.
1991: P D Wickramanayake; J Pallenschat; Volker Diehl
[Myelodysplastic syndrome (preleukemia)].
Medizinische Klinik (Munich, Germany : 1983) 1991;86(3):157-64.
1991: Angela Gause; V Roschansky; A Tschiersch; Kendall A Smith; Dirk Hasenclever; R Schmits; Volker Diehl; Michael Pfreundschuh
Low serum interleukin-2 receptor levels correlate with a good prognosis in patients with Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2 Suppl 2():43-7.
1991: Harry F Abts; Manfred Jücker; Volker Diehl; Hans Tesch
Human chronic lymphocytic leukemia cells regularly express mRNAs of the protooncogenes lck and c-fgr.
Leukemia research 1991;15(11):987-97.
1990: Andreas Engert; B Lathan; R Cremer; S Seeber; M Schulte; Volker Diehl
[Non-Hodgkin lymphoma and pregnancy].
Medizinische Klinik (Munich, Germany : 1983) 1990;85(12):734-8.
1990: Volker Diehl; C von Kalle; C Fonatsch; Hans Tesch; M Jüecker; M Schaadt
The cell of origin in Hodgkin's disease.
Seminars in oncology 1990;17(6):660-72.
1990: Klaus Wassermann; G Pothoff; W Heitz; E Kirn; Gerhard R F Krueger; Volker Diehl; G Eckert; H H Hilger
[Acute pneumocystosis during polychemotherapy following the MACOP-B protocol].
Deutsche medizinische Wochenschrift (1946) 1990;115(45):1705-11.
1990: Ugur Sahin; F Hartmann; P Senter; C Pohl; Andreas Engert; Volker Diehl; Michael Pfreundschuh
Specific activation of the prodrug mitomycin phosphate by a bispecific anti-CD30/anti-alkaline phosphatase monoclonal antibody.
Cancer research 1990;50(21):6944-8.
1990: B Bungart; Markus Loeffler; H Goris; Bert Dontje; Volker Diehl; W Nijhof
Differential effects of recombinant human colony stimulating factor (rh G-CSF) on stem cells in marrow, spleen and peripheral blood in mice.
British journal of haematology 1990;76(2):174-9.
1990: M Michels; E Schumacher; Volker Diehl; Hans Tesch
[Plasmocytoma: immunology and molecular genetics].
Medizinische Klinik (Munich, Germany : 1983) 1990;85(9):548-54.
1990: I Katay; U Wirnitzer; H Burrichter; C von Kalle; E Schell-Frederick; Volker Diehl; M Schaadt
L428 cells derived from Hodgkin's disease produce E rosette-inhibiting factor.
Blood 1990;76(4):791-6.
1990: Bernd Lathan; K Kerkhoff; W Scheithauer; Volker Diehl
In vitro drug sensitivity testing with agar-containing glass capillaries.
Anticancer research 1990;10(4):1075-8.
1990: Manfred Jücker; M Schaadt; Volker Diehl; S Poppema; D Jones; Hans Tesch
Heterogeneous expression of proto-oncogenes in Hodgkin's disease derived cell lines.
Hematological oncology 1990;8(4):191-204.
1990: Michael Pfreundschuh; C Pohl; C Berenbeck; J Schroeder; W Jung; R Schmits; A Tschiersch; Volker Diehl; Angela Gause
Detection of a soluble form of the CD30 antigen in sera of patients with lymphoma, adult T-cell leukemia and infectious mononucleosis.
International journal of cancer. Journal international du cancer 1990;45(5):869-74.
1990: Andreas Engert; G Martin; M Pfreundschuh; P Amlot; S M Hsu; Volker Diehl; P Thorpe
Antitumor effects of ricin A chain immunotoxins prepared from intact antibodies and Fab' fragments on solid human Hodgkin's disease tumors in mice.
Cancer research 1990;50(10):2929-35.
1990: Hans Tesch; Thomas Herrmann; Harry F Abts; T Diamantstein; Volker Diehl
High affinity IL-2 receptors on a Hodgkin's derived cell line.
Leukemia research 1990;14(11-12):953-60.
1990: Hans Tesch; Rudolph Zankovich; C Fonatsch; Volker Diehl
Analysis of bcr rearrangements in primary (essential) thrombocythaemia.
Leukemia research 1990;14(3):241-6.
1990: Hans Tesch; P May; G R Krueger; R Fischer; Volker Diehl
Analysis of immunoglobulin, T cell receptor and bcr rearrangements in human malignant lymphoma and Hodgkin's disease.
Oncology 1990;47(3):215-23.
1990: Andreas Engert; F Burrows; W Jung; P L Tazzari; H Stein; M Pfreundschuh; Volker Diehl; P Thorpe
Evaluation of ricin A chain-containing immunotoxins directed against the CD30 antigen as potential reagents for the treatment of Hodgkin's disease.
Cancer research 1990;50(1):84-8.
1990: Volker Diehl; Michael Pfreundschuh; Markus Loeffler; Ursula Rühl; E Hiller; HH Gerhartz; H Kirchner
Cooperative trials of Hodgkin's lymphoma in the Federal Republic of Germany.
Journal of cancer research and clinical oncology 1990;116(1):106-8.
1989: Hans Tesch; Harry F Abts; Manfred Jücker; K Mays; G Lenoir; Volker Diehl
Expression of c-fgr in EBV positive and negative B cell tumors.
Leukemia 1989;3(12):897-8.
1989: M Pfreundschuh; Volker Diehl
[Palliative medical therapy of malignant diseases].
Deutsche medizinische Wochenschrift (1946) 1989;114(46):1797-803.
1989: A Linden; Rudolph Zankovich; Peter Theissen; Volker Diehl; Harald Schicha
Malignant lymphoma: bone marrow imaging versus biopsy.
Radiology 1989;173(2):335-9.
1989: Bernd Lathan; K Kerkhoff; W Scheithauer; Daniel Von Hoff; Volker Diehl
Homogeneous growth of tumor cell colonies in agar containing glass capillaries.
Anticancer research 1989;9(6):1897-902.
1989: A Linden; Rudolph Zankovich; Peter Theissen; G Schauerte; Volker Diehl; Harald Schicha
[Bone marrow scintigraphy and magnetic resonance tomography in malignant lymphomas: comparison with histologic results].
Nuklearmedizin. Nuclear medicine 1989;28(5):166-71.
1989: E Schell-Frederick; T Tepass; G Lorscheidt; Michael Pfreundschuh; M Schaadt; Volker Diehl
Effects of recombinant tumor necrosis factor (rHuTNF alpha) on human neutrophils and monocytes: in vitro, ex vivo and in vivo.
European journal of haematology 1989;43(4):286-96.
1989: Juergen Thiele; Rudolph Zankovich; T Steinberg; R Fischer; Volker Diehl
Agnogenic myeloid metaplasia (AMM)--correlation of bone marrow lesions with laboratory data: a longitudinal clinicopathological study on 114 patients.
Hematological oncology 1989;7(5):327-43.
1989: Michael Pfreundschuh; Patrice Carde; L Da Costa; L Manil; Jean Lumbroso; B Caillou; F Boudet; Marcel Ricard; M Hayat; Volker Diehl
[In vivo imaging of Hodgkin's lymphomas using monoclonal antibodies].
Onkologie 1989;12 Suppl 1():30-3.
1989: M Pfreundschuh; Volker Diehl
[Therapy of recurrent Hodgkin's lymphoma. II. The value of bone marrow transplantation].
Deutsche medizinische Wochenschrift (1946) 1989;114(23):916-21.
1989: M Pfreundschuh; Volker Diehl
[Therapy of recurrent Hodgkin's lymphoma. I. Radiotherapy and conventional chemotherapy].
Deutsche medizinische Wochenschrift (1946) 1989;114(22):880-4.
1989: Michael Pfreundschuh; B Genth; H Kirchner; P Scheurich; A Lindemann; H T Steinmetz; M Schaadt; Volker Diehl
[Mechanism of resistance to tumor necrosis factor].
Onkologie 1989;12(3):128-30.
1989: A K von Kalle; M Schaadt; Volker Diehl
European experience with ifosfamide in lymphomas.
Seminars in oncology 1989;16(1 Suppl 3):73-7.
1989: M Schaadt; H Burrichter; Michael Pfreundschuh; E Schell-Frederick; Hans Tesch; C Fonatsch; Harald Stein; Volker Diehl
Biology of Hodgkin cell lines.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;117():53-61.
1989: J O Armitage; M J Barnett; A M Carella; K A Dicke; Volker Diehl; J G Gribben; Michael Pfreundschuh
Bone marrow transplantation in the treatment of Hodgkin's lymphoma: problems, remaining challenges, and future prospects.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;117():246-53.
1989: Harald Schicha; M Franke; J Smolorz; A Linden; W Waters; Volker Diehl
Diagnostic strategies and staging procedures for Hodgkin's lymphoma: bone marrow scintigraphy and magnetic resonance imaging.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;117():112-9.
1989: Patrice Carde; Michael Pfreundschuh; L da Costa; L Manil; Jean Lumbroso; Bernard Caillou; Claude Parmentier; J C Saccavini; Volker Diehl
Radiolabeled monoclonal antibodies against Reed-Sternberg cells for in vivo imaging of Hodgkin's disease by immunoscintigraphy.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;117():101-11.
1989: A Widding; J Smolorz; M Franke; A Linden; Volker Diehl; Harald Schicha
Bone marrow investigation with technetium-99m microcolloid and magnetic resonance imaging in patients with malignant myelolympho-proliferative diseases.
European journal of nuclear medicine 1989;15(5):230-8.
1989: Juergen Thiele; Rudolph Zankovich; T Steinberg; B Kremer; R Fischer; Volker Diehl
Primary (essential) thrombocythemia versus initial (hyperplastic) stages of agnogenic myeloid metaplasia with thrombocytosis--a critical evaluation of clinical and histomorphological data.
Acta haematologica 1989;81(4):192-202.
1989: Volker Diehl; Michael Pfreundschuh; Markus Loeffler; Ursula Rühl; E Hiller; HH Gerhartz; W Wilmanns; H Kirchner; W Schoppe; S Petsch
Chemotherapy of Hodgkin's lymphoma with alternating cycles of COPP (cyclophosphamide, vincristin, procarbazine, prednisone) and ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine). Results of the HD1 and HD3 trials of the German Hodgkin Study Group.
Medical oncology and tumor pharmacotherapy 1989;6(2):155-62.
1988: Juergen Thiele; Rudolph Zankovich; G Schneider; B Kremer; R Fischer; Volker Diehl
Primary (essential) thrombocythemia versus polycythemia vera rubra. A histomorphometric analysis of bone marrow features in trephine biopsies.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 1988;10(5):375-82.
1988: R Zankovich; Volker Diehl
[Clinical characterization of essential thrombocythemia in comparison to other myeloproliferative diseases and reactive thrombocytoses].
Klinische Wochenschrift 1988;66(15):699-702.
1988: Hans Tesch; Manfred Jücker; M H Falk; G W Bornkamm; D B Jones; Volker Diehl
Molecular analysis of Hodgkin's disease-derived cell lines.
Hematological oncology 1988;6(3):223-31.
1988: E Schell-Frederick; H Radtke; H Sommer; I Helbing; H Burrichter; M Schaadt; Volker Diehl
Inhibition of human neutrophil migration by supernatants from Hodgkin's disease-derived cell lines.
European journal of clinical investigation 1988;18(3):290-6.
1988: T Mertens; Volker Diehl
[Prevention of HIV infection in the clinic and general practice].
Der Internist 1988;29(2):131-8.
1988: E Schell-Frederick; P Ziffling; H Sommer; H Radtke; Volker Diehl
Cell migration in patients with Hodgkin's disease.
Acta paediatrica Hungarica 1988;29(1-2):213-6.
1987: Michael Pfreundschuh; W D Schoppe; R Fuchs; K H Pflüger; Markus Loeffler; Volker Diehl
Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group.
Cancer treatment reports 1987;71(12):1203-7.
1987: Volker Diehl; Michael Pfreundschuh; Markus Loeffler; K Smith; Ursula Rühl; A Georgii; E Hiller; HH Gerhartz
[Therapy studies of the German Hodgkin's Study Group. Intermediate results of the study protocols HD1, HD2, and HD3].
Onkologie 1987;10(2):62-6.
1986: Volker Diehl; Michael Pfreundschuh; F E Hauser; Markus Loeffler; Ursula Rühl; H Brücher; A Georgii; E Hiller; HH Gerhartz
[Intermediate results of therapy studies HD1, HD2 and HD3 of the German Hodgkin Study Group].
Medizinische Klinik (Munich, Germany : 1983) 1986;81(1):1-6.